A substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
| Member | Definition | Class |
|---|
| (+)-dehydrodiconiferyl alcohol | A dehydrodiconiferyl alcohol that has (2S,3R)-configuration. A natural product isolated from several plant species including Allium sativum and Codonopsis pilosula. | (+)-dehydrodiconiferyl alcohol |
| (20R)-ginsenoside Rg3 | A ginsenoside found in Panax japonicus var. major that is dammarane which is substituted by hydroxy groups at the 3beta, 12beta and 20 pro-R positions, in which the hydroxy group at position 3 has been converted to the corresponding beta-D-glucopyranosyl-beta-D-glucopyranoside, and in which a double bond has been introduced at the 24-25 position. | (20R)-ginsenoside Rg3 |
| (E)-2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside | A stilbenoid that is trans-stilbene which has been substituted by hydroxy groups at positions 2, 3, 5, and 4', and in which the hydroxy group at positon 2 has then been converted to the corresponding the beta-D-glucoside. | (E)-2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside |
| 1-O-feruloyl-beta-D-glucose | A beta-D-glucoside resulting from the formal condensation of the carboxy group of ferulic acid with the anomeric hydroxy group of beta-D-glucose. | 1-O-feruloyl-beta-D-glucose |
| 1,2,8-trihydroxy-6-methoxyxanthone | A member of the class of xanthones that is 9H-xanthen-9-one substituted by hydroxy groups at positions 1, 2 and 8 and a methoxy group at position 6. It has been isolated from various species of the genus Swertia and has been found to exhibit antioxidant activities. | swertianin |
| 2-hydroxycinnamic acid | The trans-isomer of 2-coumaric acid. | trans-2-coumaric acid |
| 2,2'-thiodiethanol | A diol that is pentane-1,5-diol in which the methylene group at position 3 is replaced by a sulfur atom | thiodiglycol |
| 2,4-di-tert-butylphenol | A member of the class of phenols carrying two tert-butyl substituents at positions 2 and 4. | 2,4-di-tert-butylphenol |
| 2,5-dihydroxybenzyl alcohol | An aromatic primary alcohol that is benzyl alcohol substituted by hydroxy groups at positions 2 and 5. | gentisyl alcohol |
| 2,6-di-tert-butylphenol | A member of the class of phenols carrying two tert-butyl substituents at positions 2 and 6. | 2,6-di-tert-butylphenol |
| 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman | | gamma-CEHC |
| 3-tert-butyl-4-hydroxyanisole | An aromatic ether that is 4-methoxyphenol in which one of the hydrogens ortho- to the phenolic hydroxy group is replaced by a tert-butyl group. | 3-tert-butyl-4-hydroxyanisole |
| 3,4-dihydroxymandelic acid | A catechol that is the 3,4-dihydroxy derivative of mandelic acid; a metabolite of L-dopa. | 3,4-dihydroxymandelic acid |
| 3,4-dihydroxyphenylethanol | A member of the class of catechols that is benzene-1,2-diol substituted by a 2-hydroxyethyl group at position 4. Isolated from Olea europaea, it exhibits antioxidant and antineoplastic activities. | hydroxytyrosol |
| 3,4-dihydroxyphenylpropionic acid | A monocarboxylic acid that is 3-phenylpropionic acid substituted by hydroxy groups at positions 3 and 4. Also known as dihydrocaffeic acid, it is a metabolite of caffeic acid and exhibits antioxidant activity. | 3-(3,4-dihydroxyphenyl)propanoic acid |
| 4-hydroxyphenylethanol | A phenol substituted at position 4 by a 2-hydroxyethyl group. | 2-(4-hydroxyphenyl)ethanol |
| 4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol | A terpineol that is 1-menthene carrying a hydroxy substituent at position 4. | 4-terpineol |
| 4-methylcatechol | A methylcatechol having a single methyl substituent at the 4-position. It has been isolated from Picea abies. | 4-methylcatechol |
| 4-methylesculetin | A hydroxycoumarin that is 4-methylcuomarin which is substituted by hydroxy groups at positions 3 and 4. A hyaluronan synthesis inhibitor. It has also been used as a fluorescent sensor to monitor the consumption of a boronic acid in Suzuki coupling reactions; fluorescence is readily detectable by the naked eye using a standard 365 nm UV lamp. | 6,7-dihydroxy-4-methylcoumarin |
| 4'-demethyldesoxypodophyllotoxin | A member of the class of furonaphthodioxoles that is (5R,5aR,8aR)-5,8,8a,9-tetrahydro-2H-furo[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one substituted at position 5 by a 4-hydroxy-3,5-dimethoxyphenyl group. | 4'-demethyldeoxypodophyllotoxin |
| 5-methoxytryptamine | A member of the class of tryptamines that is the methyl ether derivative of serotonin. | 5-methoxytryptamine |
| 5,4'-dihydroxy-7,3'-dimethoxyflavone | A dimethoxyflavone that is luteolin in which the hydroxy groups at positions 7 and 3' are replaced by methoxy groups. | velutin |
| 6-hydroxy-2,4,5-triaminopyrimidine | A member of the class of aminopyrimidines that is 2,5,6-triaminopyrimidine carrying an additional hydroxy substituent at position 4. | 2,5,6-triamino-4-hydroxypyrimidine |
| 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | A chromanol that is 6-hydroxychromane which is substituted by a carboxy group at position 2 and by methyl groups at positions 2, 5, 7, and 8. A cell-permeable, water-soluble analogue of vitamin E, it is used as a standard for measuring the antioxidant capacity of complex mixtures. | Trolox |
| 7-hydroxydehydroepiandrosterone | An androstanoid that is dehydroepiandrosterone carrying an additional hydroxy substituent at the 7alpha-position. | 7alpha-hydroxydehydroepiandrosterone |
| 7-phloroeckol | A phlorotannin that is eckol in which the hydroxy group at position 7 is replaced by a 2,4,6-trihydroxyphenoxy group. Isolated from the marine brown alga, Ecklonia cava, it exhibits antioxidant activity. | 7-phloroeckol |
| 7,3'-dihydroxy-4'-methoxyisoflavone | A member of the class of 7-hydroxyisoflavones that is 7-hydroxyisoflavone which is substituted by an additional hydroxy group at the 3' position and a methoxy group at the 4' position. | calycosin |
| 7,8-dihydroxyflavone | A dihydroxyflavone that is flavone substituted by hydroxy groups at positions 7 and 8. A dihydroxyflavone that is flavone substituted by hydroxy groups at positions 7 and 8. A naturally occurring flavonoid produced by several plants, including the weed Tridax procumbens (coalbuttons or tridax daisy) and the tree Godmania aesculifolia, In animal models, it has shown efficacy against several diseases of the nervous system, including Alzheimer's, Parkinson's, and Huntington's. | 7,8-dihydroxyflavone |
| acetylcysteine | An N-acetyl-L-amino acid that is the N-acetylated derivative of the natural amino acid L-cysteine. | N-acetyl-L-cysteine |
| acrovestone | A polyphenol that is isolated from Acronychia pedunculata and exhibits moderate antioxidant and antityrosinase activities. | acrovestone |
| ag-490 | A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2E)-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enoic acid with the amino group of benzylamine. | tyrphostin B42 |
| allose | The D-enantiomer of allopyranose. | D-allopyranose |
| alpha bitter acid | An optically active cyclic ketone consisting of 3,5,6-trihydroxycyclohexa-2,4-dien-1-one bearing two 3-methylbut-2-en-1-yl substituents at positions 4 and 6 as well as a 3-methylbutanoyl group at the 2-position. | humulone |
| alx-0600 | A 33-membered polypeptide consisting of His, Gly, Asp, Gly, Ser, Phe, Ser, Asp, Glu, Met, Asn, Thr, Ile, Leu, Asp, Asn, Leu, Ala, Ala, Arg, Asp, Phe, Ile, Asn, Trp, Leu, Ile, Gln, Thr, Lys, Ile, Thr and Asp residues joined in sequence. A glucagon-like peptide-2 receptor agonist used for the treatment of short-bowel syndrome. | teduglutide |
| amifostine anhydrous | An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy. | amifostine |
| ampelopsin | An optically active form of dihydromyricetin having (2R,3R)-configuration. | (+)-dihydromyricetin |
| arachidonoylserotonin | An N-acylserotonin obtained by formal condensation of the carboxy group of arachidonic acid with the primary amino group of serotonin. | N-arachidonoylserotonin |
| arjunolic acid | A pentacyclic triterpenoid that is olean-12-en-28-oic acid substituted by hydroxy groups at positions 2, 3 and 23 (the 2alpha,3beta stereoisomer). Isolated from Symplocos lancifolia and Juglans sinensis, it exhibits antioxidant and antimicrobial activities. | arjunolic acid |
| aspalathin | A member of the class of dihydrochalcones that is the 2-C-beta-D-glucopyranide of phloroglucinol and which is substituted at position 4 by a 3-(3,4-dihydroxyphenyl)propanoyl group. A metabolite of red bush, Aspalathus linearis (and present in the herbal tea made from the leaves), aspalathin exhibits significant hypoglycemic activity. | aspalathin |
| astaxanthine | A carotenone that consists of beta,beta-carotene-4,4'-dione bearing two hydroxy substituents at positions 3 and 3' (the 3S,3'S diastereomer). A carotenoid pigment found mainly in animals (crustaceans, echinoderms) but also occurring in plants. It can occur free (as a red pigment), as an ester, or as a blue, brown or green chromoprotein. | astaxanthin |
| astragaloside IV | A pentacyclic triterpenoid that is cycloastragenol having beta-D-xylopyranosyl and beta-D-glucopyranosyl residues attached at positions O-3 and O-6 respectively. It is isolated from Astragalus membranaceus var mongholicus. | astragaloside IV |
| astringin | A stilbenoid that is piceatannol substituted at position 3 by a beta-D-glucosyl residue. | trans-astringin |
| aurapten | A member of the class of coumarins that is umbelliferone in which the phenolic hydrogen has been replaced by a geranyl group. Ii is isolated from several edible fruits and vegetables and exhibits a variety of therapeutic properties. | auraptene |
| bacillithiol | A thiol that is the alpha-anomeric glycoside of L-cysteinyl-D-glucosamine with L-malic acid. | bacillithiol |
| baicalein | A trihydroxyflavone with the hydroxy groups at positions C-5, -6 and -7. | baicalein |
| baicalin | The glycosyloxyflavone which is the 7-O-glucuronide of baicalein. It is an active ingredient of Chinese herbal medicine Scutellaria baicalensis. | baicalin |
| benphothiamine | A thioester that is a synthetic analogue of thiamine obtained by acylative cleavage of the thiazole ring and O-phospohorylation. | benfotiamine |
| benzyl alcohol | An aromatic alcohol that consists of benzene bearing a single hydroxymethyl substituent. | benzyl alcohol |
| berberine | | berberine |
| beta carotene | A cyclic carotene obtained by dimerisation of all-trans-retinol. A strongly-coloured red-orange pigment abundant in plants and fruit and the most active and important provitamin A carotenoid. | beta-carotene |
| beta-ionone | An ionone that is but-3-en-2-one substituted by a 2,6,6-trimethylcyclohex-1-en-1-yl group at position 4. | beta-ionone |
| bilirubin | A member of the class of biladienes that is a linear tetrapyrrole with the dipyrrole units being of both exovinyl and endovinyl type. A product of heme degradation, it is produced in the reticuloendothelial system by the reduction of biliverdin and transported to the liver as a complex with serum albumin. | bilirubin IXalpha |
| brazilin | A organic heterotetracyclic compound that is a red pigment obtained from the wood of Caesalpinia echinata (Brazil-wood) or Caesalpinia sappan (sappan-wood). | brazilin |
| butein | A chalcone that is (E)-chalcone bearing four additional hydroxy substituents at positions 2', 3, 4 and 4'. | butein |
| butylated hydroxytoluene | A member of the class of phenols that is 4-methylphenol substituted by tert-butyl groups at positions 2 and 6. | 2,6-di-tert-butyl-4-methylphenol |
| cafestol | An organic heteropentacyclic compound and furan diterpenoid with formula C20H28O3 obtained from the unsaponifiable fraction of coffee oil (a lipid fraction obtained from coffee beans by organic solvent extraction). | cafestol |
| caffeic acid | A hydroxycinnamic acid that is cinnamic acid in which the phenyl ring is substituted by hydroxy groups at positions 3 and 4. It exists in cis and trans forms; the latter is the more common. | caffeic acid |
| caffeic acid phenethyl ester | An alkyl caffeate ester in which 2-phenylethyl is the alkyl component. | phenethyl caffeate |
| cannabigerol | A member of the class of resorcinols that is resorcinol which is substituted by a (2E)-3,7-dimethylocta-2,6-dien-1-yl group at position 2 and by a pentyl group at position 5. It is a natural product found in Cannabis sativa and Helichrysum species. | cannabigerol |
| capsiate | A carboxylic ester obtained by formal condensation of the carboxy group of (6E)-8-methylnon-6-enoic acid with the benzylic hydroxy group of vanillyl alcohol. A non-pungent analogue of capsaicin with a similar biological profile. | capsiate |
| carcinine | A beta-alanine derivative that is the amide obtained by formal condensation of the carboxy group of beta-alanine with the primary amino group of histamine. | 3-amino-N-[2-(1H-imidazol-5-yl)ethyl]propanamide; carcinine |
| carnosine | A dipeptide that is the N-(beta-alanyl) derivative of L-histidine. | carnosine zwitterion; carnosine |
| catechin | The (+)-enantiomer of catechin and a polyphenolic antioxidant plant metabolite. | (+)-catechin |
| celastrol | A pentacyclic triterpenoid that is 24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid bearing an oxo substituent at position 2, a hydroxy substituent at position 3 and two methyl groups at positions 9 and 13. An antioxidant and anti-inflammatory agent. Potently inhibits lipid peroxidation in mitochondria and inhibits TNF-alpha-induced NFkappaB activation. Also shown to inhibit topoisomerase II activity in vitro (IC50 = 7.41 muM). | celastrol |
| chrysin | A dihydroxyflavone in which the two hydroxy groups are located at positions 5 and 7. | chrysin |
| chrysoeriol | The 3'-O-methyl derivative of luteolin. | 4',5,7-trihydroxy-3'-methoxyflavone |
| coenzyme q10 | A ubiquinone having a side chain of 10 isoprenoid units. In the naturally occurring isomer, all isoprenyl double bonds are in the E- configuration. | coenzyme Q10 |
| corilagin | An ellagitannin with a hexahydroxydiphenoyl group bridging over the 3-O and 6-O of the glucose core. | corilagin |
| coumestrol | A member of the class of coumestans that is coumestan with hydroxy substituents at positions 3 and 9. | coumestrol |
| cryptoxanthins | A carotenol that exhibits antioxidant activity. It has been isolated from fruits such as papaya and oranges. | beta-cryptoxanthin |
| cyanidin | An anthocyanidin cation that is flavylium substituted at positions 3, 3', 4', 5 and 7 by hydroxy groups. | cyanidin cation |
| d-alpha tocopherol | An alpha-tocopherol that has R,R,R configuration. The naturally occurring stereoisomer of alpha-tocopherol, it is found particularly in sunflower and olive oils. | (R,R,R)-alpha-tocopherol |
| davidigenin | A member of the class of dihydrochalcones that is dihydrochalcone substituted by hydroxy groups at positions 4, 2', and 4' respectively. | davidigenin |
| decane-1,2-diol | A glycol that is decane bearing two hydroxy substituents located at positions 1 and 2. | decane-1,2-diol |
| demethylbellidifolin | A member of the class of xanthones that is xanthone which is substituted by hydroxy groups at positions 1, 3, 5, and 8. A natural product found particularly in Iris nigricans and Gentiana campestris. | bellidin |
| diallyl trisulfide | An organic trisulfide that is trisulfane in which both of the hydrogens are replaced by allyl groups. A component of the essential oil of garlic and a major component of the traditional Chinese medicine allitridium, it exhibits antifungal, antitumour and antioxidant activity | diallyl trisulfide |
| dihydroferulic acid | A monocarboxylic acid that is propanoic acid in which one of the hydrogens at position 3 has been replaced by a 4-hydroxy-3-methoxyphenyl group. | dihydroferulic acid |
| dihydrolipoic acid | A thio-fatty acid that is reduced form of lipoic acid. A potent antioxidant shown to directly destroy superoxide, hydroperoxy and hydroxyl radicals; also has neuroprotective and anti-tumour effects. | dihydrolipoic acid |
| diosmetin | A monomethoxyflavone that is the 4'-methyl ether derivative of luteolin. It is a natural product isolated from citrus fruits which exhibits a range of pharmacological activities. | diosmetin |
| diosmin | A disaccharide derivative that consists of diosmetin substituted by a 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. | diosmin |
| diphenylamine | An aromatic amine containing two phenyl substituents. It has been used as a fungicide for the treatment of superficial scald in apples and pears, but is no longer approved for this purpose within the European Union. | diphenylamine |
| ebselen | A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase. | ebselen |
| eckol | A phlorotannin that is oxanthrene-1,3,6,8-tetrol substituted by a 3,5-dihydroxyphenoxy moiety at position 4. Isolated from the marine brown alga, Ecklonia cava, it exhibits antioxidant activity. | eckol |
| edaravone | A pyrazolone that is 2,4-dihydro-3H-pyrazol-3-one which is substituted at positions 2 and 5 by phenyl and methyl groups, respectively. | edaravone |
| ellagic acid | An organic heterotetracyclic compound resulting from the formal dimerisation of gallic acid by oxidative aromatic coupling with intramolecular lactonisation of both carboxylic acid groups of the resulting biaryl. It is found in many fruits and vegetables, including raspberries, strawberries, cranberries, and pomegranates. | ellagic acid |
| epicatechin | A catechin with (2R,3R)-configuration. | (-)-epicatechin |
| epigallocatechin gallate | A gallate ester obtained by the formal condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin. | (-)-epigallocatechin 3-gallate |
| equilenin | A 3-hydroxy steroid that is estrone which carries two double bonds at positions 6 and 8. It is found in the urine of pregnant mare's and extensively used for estrogen replacement therapy in postmenopausal women. | equilenin |
| ergothioneine | A L-histidine derivative that is N(alpha),N(alpha),N(alpha)-trimethyl-L-histidine in which the hydrogen at position 2 on the imdazole ring is replaced by a mercapto group. A naturally occurring metabolite of histidine synthesized by bacteria and fungi with antioxidant properties. It is found ubiquitously in plants and animals and is present in many human foodstuffs. | ergothioneine thione form; ergothioneine |
| eriocitrin | A disaccharide derivative that consists of eriodictyol substituted by a 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. | eriocitrin |
| erythritol | The meso-diastereomer of butane-1,2,3,4-tetrol. | erythritol |
| esculetin | A hydroxycoumarin that is umbelliferone in which the hydrogen at position 6 is substituted by a hydroxy group. It is used in filters for absorption of ultraviolet light. | esculetin |
| esculin | A hydroxycoumarin that is the 6-O-beta-D-glucoside of esculetin. | esculin |
| ethyl protocatechuate | An ethyl ester resulting from the formal condensation of the carboxy group of 3,4-dihydroxybenzoic acid with ethanol. It is the anti-oxidative component of peanut seed testa. | ethyl 3,4-dihydroxybenzoate |
| ethyl vanillin | A member of the class of benzaldehydes that is vanillin in which the methoxy group is replaced by an ethoxy group. | ethyl vanillin |
| fangchinoline | A bisbenzylisoquinoline alkaloid that is (1beta)- berbaman which has been substituted by methyl groups at the 2 and 2' positions, by methoxy groups at the 6, 6', and 12 positions, and by a hydroxy group at position 7. Isolated from Stephania tetrandra, it has been found to possess neuroprotective and anti-tumour activity. | fangchinoline |
| fenretinide | A retinoid obtained by formal condensation of the carboxy group of all-trans retinoic acid and the anilino group of 4-hydroxyaniline. Synthetic retinoid agonist. Antiproliferative, antioxidant and anticancer agent with a long half-life in vivo. Apoptotic effects appear to be mediated by a mechanism distinct from that of 'classical' retinoids. | 4-hydroxyphenyl retinamide |
| ferrostatin-1 | An ethyl ester resulting from the formal condensation of the carboxy group of 3-amino-4-(cyclohexylamino)benzoic acid with ethanol. It is a potent inhibitor of ferroptosis, a distinct non-apoptotic form of cell death caused by lipid peroxidation. It is also a radical-trapping antioxidant and has the ability to reduce the accumulation of lipid peroxides and chain-carrying peroxyl radicals. | ferrostatin-1 |
| ferulic acid | A ferulic acid consisting of trans-cinnamic acid bearing methoxy and hydroxy substituents at positions 3 and 4 respectively on the phenyl ring. | ferulic acid |
| fisetin | A 7-hydroxyflavonol with additional hydroxy groups at positions 3, 3' and 4'. | fisetin |
| fraxetin | A hydroxycoumarin that is 6-methoxycoumarin in which the hydrogens at positions 7 and 8 have been replaced by hydroxy groups. | fraxetin |
| gallic acid | A trihydroxybenzoic acid in which the hydroxy groups are at positions 3, 4, and 5. | gallic acid |
| gallocatechol | A gallocatechin that has (2R,3S)-configuration. It is found in green tea and bananas. | (+)-gallocatechin |
| gallocatechol | A flavan-3,3',4',5,5',7-hexol having (2R,3R)-configuration. | (-)-epigallocatechin |
| gamma-terpinene | One of three isomeric monoterpenes differing in the positions of their two double bonds (alpha- and beta-terpinene being the others). In gamma-terpinene the double bonds are at the 1- and 4-positions of the p-menthane skeleton. | gamma-terpinene |
| gamma-tocotrienol | A tocotrienol that is chroman-6-ol substituted by methyl groups at positions 2, 7 and 8 and a farnesyl chain at position 2. A vitamin E family member that has potent anti-cancer properties against a wide-range of cancers. | gamma-tocotrienol |
| gardenia yellow | A diester that is crocetin in which both of the carboxy groups have been converted to their gentiobiosyl esters. It is one of the water-soluble yellow-red pigments of saffron and is used as a spice for flavouring and colouring food. Note that in India, the term 'Crocin' is also used by GlaxoSmithKline as a brand-name for paracetamol. | crocin-1 |
| genipin | | Genipin |
| germacrone | A germacrane sesquiterpenoid that has formula C15H22O. It is a natural product found in traditional medicinal plants of the family Zingiberaceae. The compound exhibits a range of pharmacological activities including anti-inflammatory, anticancer, antiviral, anti-androgenic, antioxidant, antimicrobial, antifungal, neuroprotective and insecticidal activities. | (E,E)-germacrone |
| ginsenoside rb3 | A ginsenoside found in Panax species that is dammarane which is substituted by hydroxy groups at the 3beta, 12beta and 20 pro-S positions, in which the hydroxy groups at positions 3 and 20 have been converted to the corresponding beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranoside and beta-D-xylopyranosyl-(1->6)-beta-D-glucopyranoside respectively, and in which a double bond has been introduced at the 24-25 position. | ginsenoside Rb3 |
| ginsenoside re | A ginsenoside found in Panax ginseng that is dammarane which is substituted by hydroxy groups at the 3beta, 6alpha, 12beta and 20 pro-S positions, in which the hydroxy groups at positions 6 and 20 have been converted to the corresponding alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranoside and beta-D-glucopyranoside respectively, and in which a double bond has been introduced at the 24-25 position. | ginsenoside Re |
| glyceryl ferulate | An enoate ester obtained by formal condensation of the carboxy group of trans-ferulic acid with the 1-hydroxy group of glycerol. | 1-feruloyl-sn-glycerol |
| hesperetin | A trihydroxyflavanone having the three hydroxy gropus located at the 3'-, 5- and 7-positions and an additional methoxy substituent at the 4'-position. | hesperetin |
| hispidin | Fungal metabolite first found in basidiomycete Inonotus hispidus (formerly Polyporus hispidus). | hispidin |
| hispidulin | A monomethoxyflavone that is scutellarein methylated at position 6. | hispidulin |
| hydrogen | An elemental molecule consisting of two hydrogens joined by a single bond. | dihydrogen |
| hydroquinone | A benzenediol comprising benzene core carrying two hydroxy substituents para to each other. | hydroquinone |
| icariin | A member of the class of flavonols that is kaempferol which is substituted at position 8 by a 3-methylbut-2-en-1-yl group and in which the hydroxy groups at positions 3, 4', and 7 have been converted to the corresponding 6-deoxy-alpha-L-mannopyranoside, methyl ether, and beta-D-glucopyranoside, respectively. A phoshphodiesterase-5 inhibitor, it is obtained from several species of plants in the genus Epimedium and is thought to be the main active ingredient of the Chinese herbal medicine Herba Epimedii (yinyanghuo). | icariin |
| idebenone | A member of the class of 1,4-benzoquinones which is substituted by methoxy groups at positions 2 and 3, by a methyl group at positions 5, and by a 10-hydroxydecyl group at positions 6. Initially developed for the treatment of Alzheimer's disease, benefits were modest; it was subsequently found to be of benefit for the symptomatic treatment of Friedreich's ataxia. | idebenone |
| isoferulic acid | A ferulic acid consisting of trans-cinnamic acid bearing methoxy and hydroxy substituents at positions 4 and 3 respectively on the phenyl ring. | isoferulic acid |
| isonaringin | A disaccharide derivative that is (S)-naringenin substituted by a 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. | narirutin |
| isopentenyl pyrophosphate | A prenol phosphate comprising 3-methylbut-3-en-1-ol having an O-diphosphate substituent. | isopentenyl diphosphate |
| isosalipurposide | A monosaccharide derivative that is trans-chalcone substituted by hydroxy groups at positions 4, 4' and 6 and a beta-D-glucopyranosyloxy group at position 2' respectively. | phlorizin chalcone |
| kahweol | A diterpenoid with formula C20H26O3, isolated from the beans of Coffea arabica. It exhibits antioxidant, anti-inflammatory, anti-angiogenesis and anti-proliferative properties. | kahweol |
| knipholone | An anthraquinone that is anthracene-9,10-dione substituted by hydroxy groups at positions 4 and 6, a methyl group at position 2 and a 3-acetyl-2,6-dihydroxy-4-methoxyphenyl group at position 1. It exhibits antioxidant, cytotoxic and antiplasmodial activities. | knipholone |
| kurarinol | A trihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 7, 2' and 4' , a methoxy group at position 5 and a (2S)-5-hydroxy-5-methyl-2-(prop-1-en-2-yl)hexyl group at position 8 respectively. | kurarinol |
| lactobionic acid | A disaccharide formed between beta-D-galactose and D-gluconic acid. | lactobionic acid |
| liproxstatin-1 | An azaspiro compound that is 1'H-spiro[piperidine-4,2'-quinoxaline] in which the hydrogen at position 3' is replaced by a (3-chlorobenzyl)amino group. It is a potent inhibitor of ferroptosis. | liproxstatin-1 |
| luteolin-7-glucoside | A glycosyloxyflavone that is luteolin substituted by a beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. | luteolin 7-O-beta-D-glucoside |
| lycopene | An acyclic carotene commonly obtained from tomatoes and other red fruits. | lycopene |
| madecassic acid | A pentacyclic triterpenoid that is ursane substituted by a carboxy group at position 28 and hydroxy groups at positions 2, 3, 6 and 23 (the 2alpha,3beta,6beta stereoisomer). | madecassic acid |
| madecassoside | A triterpenoid saponin that is a trisaccharide derivative of madecassic acid. Isolated from Centella asiatica, it exhibits anti-inflammatory, antioxidant and antirheumatic activities. | madecassoside |
| mangiferin | A C-glycosyl compound consisting of 1,3,6,7-tetrahydroxyxanthen-9-one having a beta-D-glucosyl residue at the 6-position. | mangiferin |
| mangostin | A member of the class of xanthones that is 9H-xanthene substituted by hydroxy group at positions 1, 3 and 6, a methoxy group at position 7, an oxo group at position 9 and prenyl groups at positions 2 and 8. Isolated from the stems of Cratoxylum cochinchinense, it exhibits antioxidant, antimicrobial and antitumour activities. | alpha-mangostin |
| maslinic acid | A pentacyclic triterpenoid that is olean-12-ene substituted by hydroxy groups at positions 2 and 3 and a carboxy group at position 28 (the 2alpha,3beta stereoisomer). It is isolated from Olea europaea and Salvia canariensis and exhibits anti-inflammatory, antioxidant and antineoplastic activity. | maslinic acid |
| masoprocol | A tetrol that is butane which is substituted at positions 2 and 3 by 3,4-dihydroxybenzyl groups. Masoprocol, the meso-form found in the leaves of the creosote bush (Larrea divaricata), is a potent lipoxygenase inhibitor. | nordihydroguaiaretic acid |
| medroxyprogesterone acetate | An acetate ester resulting from the formal condensation of the 17alpha-hydroxy group of medroxyprogesterone with the carboxy group of acetic acid. A widely used progestin in menopausal hormone therapy and in progestogen-only birth control. | medroxyprogesterone acetate |
| menatetrenone | A menaquinone whose side-chain contains 4 isoprene units in an all-trans-configuration. | menaquinone-4 |
| meso-zeaxanthin | A carotenol that is beta,beta-carotene carrying two hydroxy substituents at positions 3 and 3' (the 3R,3'S-diastereomer). It is rarely found in diet and is believed to be formed at the macula by metabolic transformations of ingested carotenoids. | meso-zeaxanthin |
| methyl 3,4-dihydroxybenzoate | A methyl ester resulting from the formal condensation of the carboxy group of 3,4-dihydroxybenzoic acid with methanol. | methyl 3,4-dihydroxybenzoate |
| methyl gallate | A gallate ester obtained by the formal condensation of gallic acid with methanol. It exhibits anti-oxidant, anti-tumor, anti-microbial and anti-inflammatory properties. | methyl 3,4,5-trihydroxybenzoate |
| methyl vanillate | A benzoate ester that is the methyl ester of vanillic acid. | methyl vanillate |
| methylene blue | An organic chloride salt having 3,7-bis(dimethylamino)phenothiazin-5-ium as the counterion. A commonly used dye that also exhibits antioxidant, antimalarial, antidepressant and cardioprotective properties. | methylene blue |
| molsidomine | A member of the class of oxadiazoles that is 1,2,3-oxadiazole substituted by morpholin-4-yl and (ethoxycarbonyl)azanidyl groups at positions 3 and 5, respectively. It is used as a vasodilator drug for the treatment of myocardial ischemic syndrome and congestive heart failure. | 1-ethoxy-N-[3-(4-morpholinyl)-5-oxadiazol-3-iumyl]methanimidate; molsidomine |
| molsidomine | A member of the class of oxadiazoles that is 1,2,3-oxadiazole substituted by morpholin-4-yl and (ethoxycarbonyl)azanidyl groups at positions 3 and 5, respectively. It is used as a vasodilator drug for the treatment of myocardial ischemic syndrome and congestive heart failure. | 1-ethoxy-N-[3-(4-morpholinyl)-5-oxadiazol-3-iumyl]methanimidate; molsidomine |
| monomethyl fumarate | A dicarboxylic acid monoester resulting from the formal condensation of one of the carboxy groups of fumaric acid with methanol. Is is a metabolite of dimethyl fumarate and used for the the treatment of patients with relapsing multiple sclerosis (MS). It also induces the NFE2L2 (Nrf2) transcription factor by binding to KEAP1. | monomethyl fumarate |
| morin | A pentahydroxyflavone that is 7-hydroxyflavonol bearing three additional hydroxy substituents at positions 2' 4' and 5. | morin |
| myricetin | A hexahydroxyflavone that is flavone substituted by hydroxy groups at positions 3, 3', 4', 5, 5' and 7. It has been isolated from the leaves of Myrica rubra and other plants. | myricetin |
| n-acetylaspartic acid | An N-acyl-L-aspartic acid in which the acyl group is specified as acetyl. | N-acetyl-L-aspartic acid |
| n-acetylneuraminic acid | An N-acylneuraminic acid where the N-acyl group is specified as acetyl. | N-acetylneuraminic acid |
| n-acetylserotonin | An N-acylserotonin resulting from the formal condensation of the primary amino group of serotonin with the carboxy group of acetic acid. | N-acetylserotonin |
| n-isopropyl-n-phenyl-4-phenylenediamine | The N-substituted diamine that is 1,4-phenylenediamine substituted at one N with an isopropyl group and at the other with a phenyl group. | N-isopropyl-N'-phenyl-p-phenylenediamine |
| n,n'-diphenyl-4-phenylenediamine | An N-substituted diamine that is 1,4-phenylenediamine in which one hydrogen from each amino group is replaced by a phenyl group. | N,N'-diphenyl-1,4-phenylenediamine |
| niacinamide | A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group. | nicotinamide |
| nigerloxin | A member of the class of benzoic acids that is benzoic acid which is substituted at positions 2, 3, 4, 5, and 6 by carbamoyl, hydroxy, E)-prop-1-en-1-yl, methyl, and methoxy groups, respectively. Obtained from solid-state fermentation of Aspergillus niger CFR-W-105, it inhibits soy bean lipoxygenase-1 (LOX-1) and rat lens aldose reductase (RLAR). It also shows free radical scavenging activity. | nigerloxin |
| nk 104 | The calcium salt of pitavastatin. Used for treatment of hypercholesterolemia (elevated levels of cholesterol in the blood) on patients unable to sufficiently lower their cholesterol levels by diet and exercise. | pitavastatin calcium |
| norwogonin | A trihydroxyflavone with the hydroxy groups at positions C-5, -7 and -8. | norwogonin |
| notoginsenoside r1 | A ginsenoside found in Panax notoginseng that is dammarane which is substituted by hydroxy groups at the 3beta, 6alpha, 12beta and 20 pro-S positions, in which the hydroxy groups at positions 6 and 20 have been converted to the corresponding beta-D-xylopyranosyl-(1->2)-beta-D-glucopyranoside and beta-D-glucopyranoside respectively, and in which a double bond has been introduced at the 24-25 position. | notoginsenoside R1 |
| oleic acid | An octadec-9-enoic acid in which the double bond at C-9 has Z (cis) stereochemistry. | oleic acid |
| oleuropein | A secoiridoid glycoside that is the methyl ester of 3,4-dihydro-2H-pyran-5-carboxylic acid which is substituted at positions 2, 3, and 4 by hydroxy, ethylidene, and carboxymethyl groups, respectively and in which the anomeric hydroxy group at position 2 has been converted into its beta-D-glucoside and the carboxylic acid moiety of the carboxymethyl substituent has been converted to the corresponding 3,4-dihydroxyphenethyl ester (the 2S,3E,4S stereoisomer). The most important phenolic compound present in olive cultivars. | oleuropein |
| oleuropein aglycone | A secoiridoid that is the methyl ester of 3,4-dihydro-2H-pyran-5-carboxylic acid which is substituted at positions 2, 3, and 4 by hydroxy, ethylidene, and carboxymethyl groups, respectively and in which the carboxylic acid moiety of the carboxymethyl substituent has been converted to the corresponding 3,4-dihydroxyphenethyl ester (the 2R,3E,4S stereoisomer). The most important phenolic compound present in olive cultivars. | oleuropein aglycone |
| oltipraz | A 1,2-dithiole that is 3H-1,2-dithiole-3-thione substituted at positions 4 and 5 by methyl and pyrazin-2-yl groups respectively. | oltipraz |
| orientin | A C-glycosyl compound that is luteolin substituted by a beta-D-glucopyranosyl moiety at position 8. | orientin |
| ovothiol a | A L-histidine derivative that is L-histidine substituted at positions N3 and C5 on the imidazole ring by methyl and mercapto groups respectively. | ovothiol A zwitterion; ovothiol A |
| ovothiol c | A L-histidine derivative that is N,N-dimethyl-L-histidine substituted at positions N3 and C5 on the imidazole ring by methyl and mercapto groups respectively. | ovothiol C zwitterion; ovothiol C |
| pallidol | A tetracyclic stilbenoid that is a homodimer obtained by cyclodimerisation of resveratrol. | pallidol |
| patuletin | A trimethoxyflavone that is quercetagetin methylated at position 6. | patuletin |
| pectolinarin | A disaccharide derivative that consists of pectolinarigenin substituted by a 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. | pectolinarin |
| peonidin | An anthocyanidin cation that is flavylium bearing four hydroxy substituents at positions 3, 4', 5 and 7 as well as a methoxy substituent at position 3'. | peonidin |
| petunidin-3-glucoside | An anthocyanin cation that is petunidin substituted at position 3 by a beta-D-glucosyl residue | petunidin 3-O-beta-D-glucoside |
| phlorhizin | An aryl beta-D-glucoside that is phloretin attached to a beta-D-glucopyranosyl residue at position 2' via a glycosidic linkage. | phlorizin |
| pinobanksin | A trihydroxyflavanone in which the three hydroxy substituents are located at positions 3, 5 and 7. | pinobanksin |
| pinocembrin | A dihydroxyflavanone in which the two hydroxy groups are located at positions 5 and 7. A natural product found in Piper sarmentosum and Cryptocarya chartacea. | pinocembrin |
| piperlactam s | An organic heterotetracyclic compound that is dibenzo[cd,f]indol-4(5H)-one carrying two methoxy substituents at positions 1 and 5 as well as a hydroxy substituent at position 2. | piperlactam S |
| pitavastatin | A dihydroxy monocarboxylic acid that is (6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]hept-6-enoic acid in which the two hydroxy groups are located at positions 3 and 5 (the 3R,5S-stereoisomer). Used as its calcium salt for treatment of hypercholesterolemia (elevated levels of cholesterol in the blood) on patients unable to sufficiently lower their cholesterol levels by diet and exercise. | pitavastatin |
| polydatin | A stilbenoid that is trans-resveratrol substituted at position 3 by a beta-D-glucosyl residue. | trans-piceid |
| pqq cofactor | A pyrroloquinoline having oxo groups at the 4- and 5-positions and carboxy groups at the 2-, 7- and 9-positions. | pyrroloquinoline quinone |
| proanthocyanidin a2 | A proanthocyanidin obtained by the condensation of (-)-epicatechin units. | proanthocyanidin A2 |
| probucol | A dithioketal that is propane-2,2-dithiol in which the hydrogens attached to both sulfur atoms are replaced by 3,5-di-tert-butyl-4-hydroxyphenyl groups. An anticholesteremic drug with antioxidant and anti-inflammatory properties, it is used to treat high levels of cholesterol in blood. | probucol |
| procyanidin b2 | A proanthocyanidin consisting of two molecules of (-)-epicatechin joined by a bond between positions 4 and 8' in a beta-configuration. Procyanidin B2 can be found in Cinchona pubescens (Chinchona, in the rind, bark and cortex), in Cinnamomum verum (Ceylon cinnamon, in the rind, bark and cortex), in Crataegus monogyna (Common hawthorn, in the flower and blossom), in Uncaria guianensis (Cat's claw, in the root), in Vitis vinifera (Common grape vine, in the leaf), in Litchi chinensis (litchi, in the pericarp), in the apple, in Ecdysanthera utilis and in red wine. | procyanidin B2 |
| procyanidin b3 | A proanthocyanidin consisting of two molecules of (+)-catechin joined by a bond between positions 4 and 8' in alpha-configuration. It can be found in red wine, in barley, in beer, in peach or in Jatropha macrantha, the Huanarpo Macho. | procyanidin B3 |
| procyanidin C1 | A proanthocyanidin consisting of three (-)-epicatechin units joined by two successive (4beta->8)-linkages. | procyanidin C1 |
| propylthiouracil | A pyrimidinethione consisting of uracil in which the 2-oxo group is substituted by a thio group and the hydrogen at position 6 is substituted by a propyl group. | 6-propyl-2-thiouracil |
| pterostilbene | A stilbenol that consists of trans-stilbene bearing a hydroxy group at position 4 as well as two methoxy substituents at positions 3' and 5'. | pterostilbene |
| putrescine | A four-carbon alkane-alpha,omega-diamine. It is obtained by the breakdown of amino acids and is responsible for the foul odour of putrefying flesh. | putrescine |
| pyranonigrin a | A member of the class of pyranopyrroles that is 2-[(1E)-prop-1-en-1-yl]-6,7-dihydropyrano[2,3-c]pyrrole-4,5-dione carrying two additional hydroxy substituents at positions 3 and 7. Originally isolated from Aspergillus niger. | pyranonigrin A |
| quadrangularin a | An indane-derived stilbenoid that is a homodimer obtained by cyclodimerisation of resveratrol. | quadrangularin A |
| quercetagetin | A hexahydroxyflavone that is flavone substituted by hydroxy groups at positions 3, 5, 6, 7, 3' and 4' respectively. | quercetagetin |
| quercetin | A pentahydroxyflavone having the five hydroxy groups placed at the 3-, 3'-, 4'-, 5- and 7-positions. It is one of the most abundant flavonoids in edible vegetables, fruit and wine. | quercetin |
| quercetin 3-o-glucopyranoside | A quercetin O-glucoside that is quercetin with a beta-D-glucosyl residue attached at position 3. Isolated from Lepisorus contortus, it exhibits antineoplastic activityand has been found to decrease the rate of polymerization and sickling of red blood cells | quercetin 3-O-beta-D-glucopyranoside |
| quercetin 3-o-glucuronide | A quercetin O-glycoside that consists of quercetin attached to a beta-D-glucuronopyranosyl moiety at position 3 via a glycosidic linkage. Isolated from Salvia and Phaseolus vulgaris, it exhibits antioxidant and antidepressant activities. | miquelianin |
| quercetin 3-sambubioside | A quercetin O-glucoside that is quercetin attached to a beta-D-sambubiosyl residue at position 3 via a glycosidc linkage. | 2)-beta-D-glucoside].html>quercetin 3-O-[beta-D-xylosyl-(1->2)-beta-D-glucoside] |
| quercetin-3-o-sophoroside | A quercetin O-glucoside that is quercetin attached to a beta-D-sophorosyl residue at position 3 via a glycosidic linkage. | 2)-beta-D-glucoside.html>quercetin 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside |
| quercimeritrin | A quercetin O-glucoside in which a glucosyl residue is attached at position 7 of quercetin via a beta-glycosidic linkage. | quercetin 7-O-beta-D-glucoside |
| quercitrin | A quercetin O-glycoside that is quercetin substituted by a alpha-L-rhamnosyl moiety at position 3 via a glycosidic linkage. | quercitrin |
| resveratrol | A stilbenol that is stilbene in which the phenyl groups are substituted at positions 3, 5, and 4' by hydroxy groups. | resveratrol |
| resveratrol | A resveratrol in which the double bond has E configuration. | trans-resveratrol |
| retinol palmitate | An all-trans-retinyl ester obtained by formal condensation of the carboxy group of palmitic (hexadecanoic acid) with the hydroxy group of all-trans-retinol. It is used in cosmetic products to treat various skin disorders such as acne, skin aging, wrinkles, dark spots, and also protect against psoriasis. | all-trans-retinyl palmitate |
| rhamnetin | A monomethoxyflavone that is quercetin methylated at position 7. | rhamnetin |
| riboflavin | D-Ribitol in which the hydroxy group at position 5 is substituted by a 7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl moiety. It is a nutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables, but the richest natural source is yeast. The free form occurs only in the retina of the eye, in whey, and in urine; its principal forms in tissues and cells are as flavin mononucleotide and flavin-adenine dinucleotide. | riboflavin |
| robustaflavone | A biflavonoid that is obtained by oxidative coupling of two molecules of apigenin resulting in a bond between positions C-3 of the hydroxyphenyl ring and C-6 of the chromene ring. Isolated from Thuja orientalis and Rhus succedanea it exhibits antioxidant, cytotoxic and anti-hepatitis B activity. | robustaflavone |
| rosmarinic acid | The 1-carboxy-2-(2,4-dihydroxyphenyl)ethyl ester of trans-caffeic acid. | rosmarinic acid |
| rubiadin | A dihydroxyanthraquinone that is anthracene-9,10-dione substituted by hydroxy groups at positions 1 and 3 and a methyl group at position 2. It has been isolated from Rubia yunnanensis. | rubiadin |
| rutin | A rutinoside that is quercetin with the hydroxy group at position C-3 substituted with glucose and rhamnose sugar groups. | rutin |
| salvianolic acid B | A member of the class of 1-benzofurans that is an antioxidant and free radical scavenging compound extracted from S. miltiorrhiza | salvianolic acid B |
| salvin | An abietane diterpenoid that is abieta-8,11,13-triene substituted by hydroxy groups at positions 11 and 12 and a carboxy group at position 20. It is isolated from rosemary (Rosmarinus officinalis) and common sage (Salvia officinalis) and exhibits anti-angiogenic, antineoplastic, antioxidant and anti-HIV activity. | carnosic acid |
| sappanchalcone | A member of the class of chalcones that consists of trans-chalcone substituted by hydroxy groups at positions 3, 4 and 4' and a methoxy group at position 2'. Isolated from Caesalpinia sappan, it exhibits neuroprotective and cytoprotective activity. | sappanchalcone |
| sb 415286 | A member of the class of maleimides carrying 3-chloro-4-hydroxyphenylamino and 2-nitrophenyl substituents at positions 3 and 4 respectively. | SB 415286 |
| schizandrin b | An organic heterotetracyclic compound that is found in Fructus Schisandrae and Schisandra chinensis. | (+)-schisandrin B; Deoxygomisin A |
| secoxyloganin | A secoiridoid glycoside that is [(2R,3R,4S)-2-hydroxy-5-(methoxycarbonyl)-3-vinyl-3,4-dihydro-2H-pyran-4-yl]acetic acid in which the anometric hydroxy group has been converted to the corresponding beta-D-glucoside. It has been isolated from several plant species and exhibits antioxidant and anti-allergic properties. | secoxyloganin |
| sesaminol | A furofuran that is cis-tetrahydro-1H,3H-furo[3,4-c]furan substituted by a 6-hydroxy-1,3-benzodioxol-5-yl group at position 1S and a 1,3-benzodioxol-5-yl group at position 4S. It is metabolite found in sesame seeds. | sesaminol |
| silybin | A flavonolignan isolated from milk thistle, Silybum marianum, that has been shown to exhibit antioxidant and antineoplastic activities. | silibinin |
| sinapine | An acylcholine in which the acyl group specified is sinapoyl. | sinapine |
| sitosterol, (3beta)-isomer | A member of the class of phytosterols that is stigmast-5-ene substituted by a beta-hydroxy group at position 3. | sitosterol |
| solasodine | An oxaspiro compound and steroid alkaloid sapogenin with formula C27H43NO2 found in the Solanum (nightshade) family. It is used as a precursor in the synthesis of complex steroidal compounds such as contraceptive pills. | solasodine |
| sorbinil | An azaspiro compound having a monofluoro-substituted chromane skeleton spiro-linked to an imidazolidinedione ring. | sorbinil |
| spermine | A polyazaalkane that is tetradecane in which the carbons at positions 1, 5, 10 and 14 are replaced by nitrogens. Spermine has broad actions on cellular metabolism. | spermine |
| spiraeoside | A quercetin O-glucoside that is quercetin with a beta-D-glucosyl residue attached at position 4'. | quercetin 4'-O-beta-D-glucopyranoside |
| staphyloxanthin | A xanthophyll that is beta-D-glucopyranose in which the hydroxy groups at positions 1 and 6 have been acylated by an all-trans-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,22-decaenoyl group and a 12-methyltetradecanoyl group, respectively. Staphyloxanthin is responsible for the characteristic yellow-golden colour which gives the bacterium Staphylococcus aureus its name. | staphyloxanthin |
| stevioside | A diterpene glycoside that is rubusoside in which the hydroxy group at position 2 of the allylic beta-D-glucoside has been converted to the corresponding beta-D-glucoside. It is a natural herbal sweetener that is 250-300 times sweeter than sucrose (though with a bitter aftertaste), extracted from the Stevia rebaudiana plant native to South America. | stevioside |
| sugiol | An abietane diterpenoid that is ferruginol in which the methylene group para to the phenolic hydroxy group has been substituted by an oxo group. | sugiol |
| sulforaphane | An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen. | sulforaphane |
| swertisin | A flavone C-glycoside that is 7-O-methylapigenin in which the hydrogen at position 6 has been replaced by a beta-D-glucosyl residue. | swertisin |
| tamarixetin | A monomethoxyflavone that is quercetin methylated at position O-4'. Isolated from Cyperus teneriffae. | tamarixetin |
| taurine | An amino sulfonic acid that is the 2-amino derivative of ethanesulfonic acid. It is a naturally occurring amino acid derived from methionine and cysteine metabolism. An abundant component of fish- and meat-based foods, it has been used as an oral supplement in the treatment of disorders such as cystic fibrosis and hypertension. | taurine zwitterion; taurine |
| thiazolidine-4-carboxylic acid | A sulfur-containing amino acid that is proline in which the methylene group at position 4 is replaced by a sulfur atom. | thioproline zwitterion; thioproline |
| thiazolidine-4-carboxylic acid | An alpha-amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of thioproline; major species at pH 7.3. | thioproline zwitterion; thioproline |
| thiourea | The simplest member of the thiourea class, consisting of urea with the oxygen atom substituted by sulfur. | thiourea |
| thymoquinone | A member of the class of 1,4-benzoquinones that is 1,4-bezoquinone in which the hydrogens at positions 2 and 5 are replaced by methyl and isopropyl groups, respectively. It is a natural compound isolated from Nigella sativa which has demonstrated promising chemotherapeutic activity. | thymoquinone |
| tln 4601 | | diazepinomicin |
| tretinoin | A retinoic acid in which all four exocyclic double bonds have E- (trans-) geometry. | all-trans-retinoic acid |
| triethylenediamine | An organic heterobicylic compound that is piperazine with an ethane-1,2-diyl group forming a bridge between N1 and N4. It is typically used as a catalyst in polymerization reactions. | triethylenediamine |
| trilobatin | An aryl beta-D-glucoside that is phloretin attached to a beta-D-glucopyranosyl residue at position 4' via a glycosidic linkage. It is isolated from the leaves of the Chinese sweet tea Lithocarpus polystachyus and exhibits significant anti-hyperglycemic, anti-oxidative and anti-inflammatory properties. | trilobatin |
| troglitazone | | troglitazone |
| u 0126 | An aryl sulfide that is (2Z,3Z)-bis[amino(sulfanyl)methylidene]butanedinitrile in which the sulfanyl hydrogens are replaced by 2-aminophenyl groups. An inhibitor of mitogen-activated protein kinase that also exhibits anti-cancer properties. | U0126 |
| ubiquinone 9 | | ubiquinone-9 |
| vanillin | A member of the class of benzaldehydes carrying methoxy and hydroxy substituents at positions 3 and 4 respectively. | vanillin |
| vexibinol | A tetrahydroxyflavanone having a structure of naringenin bearing an additional hydroxyl substituent at position 2' as well as a (2R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl (lavandulyl) substituent at position 8'. | sophoraflavanone G |
| wr 1065 | An alkanethiol that is the N-3-aminopropyl derivative of cysteamine. Used as the S-phosphorylated prodrug, amifostine, for cytoprotection in cancer chemotherapy and radiotherapy. | WR-1065 |
| zeaxanthin | | zeaxanthin |
| zingerone | A methyl ketone that is 4-phenylbutan-2-one in which the phenyl ring is substituted at positions 3 and 4 by methoxy and hydroxy groups respectively. The major pungent component in ginger. | zingerone |
| zonisamide | A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position. | zonisamide |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | Homo sapiens (human) | Potency | 17.3277 | 1 | 57 |
| 15-lipoxygenase, partial | Homo sapiens (human) | Potency | 8.0545 | 1 | 27 |
| 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | Leishmania major strain Friedlin | Potency | 7.5686 | 1 | 1 |
| 67.9K protein | Vaccinia virus | Potency | 17.0265 | 2 | 24 |
| acetylcholinesterase | Homo sapiens (human) | Potency | 34.6091 | 4 | 39 |
| acid sphingomyelinase | Homo sapiens (human) | Potency | 54.4152 | 1 | 3 |
| activating transcription factor 6 | Homo sapiens (human) | Potency | 37.1998 | 2 | 25 |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | Potency | 10.0000 | 1 | 1 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 21.8961 | 1 | 82 |
| alpha-galactosidase | Homo sapiens (human) | Potency | 27.7793 | 4 | 10 |
| Alpha-synuclein | Homo sapiens (human) | Potency | 12.2607 | 1 | 9 |
| Amyloid-beta precursor protein | Homo sapiens (human) | Potency | 16.3601 | 1 | 1 |
| apical membrane antigen 1, AMA1 | Plasmodium falciparum 3D7 | Potency | 11.9165 | 1 | 13 |
| AR protein | Homo sapiens (human) | Potency | 21.8535 | 12 | 279 |
| aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 28.1820 | 3 | 65 |
| arylsulfatase A | Homo sapiens (human) | Potency | 19.8890 | 1 | 13 |
| ATAD5 protein, partial | Homo sapiens (human) | Potency | 14.0557 | 4 | 33 |
| Ataxin-2 | Homo sapiens (human) | Potency | 23.9861 | 2 | 20 |
| ATP-dependent phosphofructokinase | Trypanosoma brucei brucei TREU927 | Potency | 13.9075 | 5 | 38 |
| ATPase family AAA domain-containing protein 5 | Homo sapiens (human) | Potency | 25.1609 | 2 | 22 |
| atrial natriuretic peptide receptor 1 precursor | Homo sapiens (human) | Potency | 15.3398 | 1 | 2 |
| atrial natriuretic peptide receptor 2 precursor | Homo sapiens (human) | Potency | 23.4354 | 1 | 2 |
| beta-2 adrenergic receptor | Homo sapiens (human) | Potency | 11.4012 | 2 | 2 |
| Bloom syndrome protein isoform 1 | Homo sapiens (human) | Potency | 26.0012 | 2 | 47 |
| BRCA1 | Homo sapiens (human) | Potency | 11.8257 | 1 | 9 |
| bromodomain adjacent to zinc finger domain 2B | Homo sapiens (human) | Potency | 46.6786 | 1 | 19 |
| C-terminal-binding protein 1 | Homo sapiens (human) | Potency | 16.9469 | 1 | 1 |
| caspase 7, apoptosis-related cysteine protease | Homo sapiens (human) | Potency | 31.2768 | 1 | 9 |
| caspase-1 isoform alpha precursor | Homo sapiens (human) | Potency | 22.2226 | 1 | 9 |
| caspase-3 | Cricetulus griseus (Chinese hamster) | Potency | 47.3185 | 1 | 8 |
| caspase-3 | Homo sapiens (human) | Potency | 31.2768 | 1 | 9 |
| Caspase-7 | Cricetulus griseus (Chinese hamster) | Potency | 47.3185 | 1 | 8 |
| Caspase-7 | Homo sapiens (human) | Potency | 16.7724 | 1 | 9 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 40.1665 | 3 | 79 |
| cellular tumor antigen p53 isoform a | Homo sapiens (human) | Potency | 15.7352 | 2 | 31 |
| Chain A, 2-oxoglutarate Oxygenase | Homo sapiens (human) | Potency | 18.8653 | 1 | 72 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | Homo sapiens (human) | Potency | 16.5236 | 4 | 47 |
| Chain A, Beta-lactamase | Escherichia coli K-12 | Potency | 37.1307 | 2 | 22 |
| Chain A, Breast cancer type 1 susceptibility protein | Homo sapiens (human) | Potency | 7.9433 | 1 | 1 |
| Chain A, Cruzipain | Trypanosoma cruzi | Potency | 27.1197 | 2 | 22 |
| Chain A, Ferritin light chain | Equus caballus (horse) | Potency | 23.9570 | 2 | 18 |
| Chain A, HADH2 protein | Homo sapiens (human) | Potency | 12.5044 | 2 | 75 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | Homo sapiens (human) | Potency | 41.3216 | 1 | 27 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | Homo sapiens (human) | Potency | 12.0722 | 4 | 90 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | 15.3621 | 3 | 46 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | Homo sapiens (human) | Potency | 16.6558 | 2 | 59 |
| Chain B, HADH2 protein | Homo sapiens (human) | Potency | 12.5044 | 2 | 75 |
| chaperonin-containing TCP-1 beta subunit homolog | Homo sapiens (human) | Potency | 61.1936 | 1 | 2 |
| chromobox protein homolog 1 | Homo sapiens (human) | Potency | 44.7747 | 2 | 30 |
| ClpP | Bacillus subtilis | Potency | 22.3209 | 1 | 4 |
| core-binding factor subunit beta isoform 2 | Homo sapiens (human) | Potency | 0.3604 | 2 | 2 |
| CREB-binding protein | Homo sapiens (human) | Potency | 17.0453 | 2 | 4 |
| cytochrome P450 2C19 precursor | Homo sapiens (human) | Potency | 15.7976 | 1 | 22 |
| cytochrome P450 2C9 precursor | Homo sapiens (human) | Potency | 14.3847 | 1 | 21 |
| cytochrome P450 2C9, partial | Homo sapiens (human) | Potency | 12.3069 | 1 | 15 |
| cytochrome P450 2D6 | Homo sapiens (human) | Potency | 19.4299 | 1 | 11 |
| cytochrome P450 2D6 isoform 1 | Homo sapiens (human) | Potency | 21.3092 | 1 | 15 |
| cytochrome P450 3A4 isoform 1 | Homo sapiens (human) | Potency | 19.4935 | 2 | 90 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | Homo sapiens (human) | Potency | 11.9454 | 2 | 25 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 31.8876 | 1 | 35 |
| D(1A) dopamine receptor | Homo sapiens (human) | Potency | 8.4196 | 3 | 10 |
| D(1A) dopamine receptor | Sus scrofa (pig) | Potency | 8.4798 | 1 | 4 |
| Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) | Potency | 10.8782 | 1 | 4 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | Homo sapiens (human) | Potency | 24.4712 | 1 | 3 |
| DNA polymerase beta | Homo sapiens (human) | Potency | 18.4666 | 1 | 25 |
| DNA polymerase eta isoform 1 | Homo sapiens (human) | Potency | 23.2175 | 2 | 23 |
| DNA polymerase III, partial | Bacillus subtilis | Potency | 12.6286 | 1 | 6 |
| DNA polymerase iota isoform a (long) | Homo sapiens (human) | Potency | 28.5431 | 2 | 41 |
| DNA polymerase kappa isoform 1 | Homo sapiens (human) | Potency | 14.9558 | 2 | 75 |
| dopamine D1 receptor | Homo sapiens (human) | Potency | 5.7585 | 1 | 4 |
| endonuclease IV | Escherichia coli | Potency | 16.3140 | 2 | 10 |
| Endothelin receptor type B | Rattus norvegicus (Norway rat) | Potency | 18.6730 | 1 | 3 |
| Endothelin-1 receptor | Rattus norvegicus (Norway rat) | Potency | 18.6730 | 1 | 3 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 24.9280 | 12 | 322 |
| estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 29.4536 | 3 | 58 |
| estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 23.0876 | 10 | 237 |
| euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 15.5020 | 1 | 70 |
| EWS/FLI fusion protein | Homo sapiens (human) | Potency | 19.4393 | 4 | 55 |
| eyes absent homolog 2 isoform a | Homo sapiens (human) | Potency | 6.6350 | 1 | 2 |
| farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 33.3384 | 5 | 54 |
| flap endonuclease 1 | Homo sapiens (human) | Potency | 21.4496 | 3 | 44 |
| fructose-bisphosphate aldolase A | Oryctolagus cuniculus (rabbit) | Potency | 57.8319 | 1 | 4 |
| Fumarate hydratase | Homo sapiens (human) | Potency | 21.2382 | 1 | 7 |
| G | Vesicular stomatitis virus | Potency | 12.3069 | 1 | 15 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Potency | 19.3434 | 1 | 46 |
| galactokinase | Homo sapiens (human) | Potency | 26.0642 | 2 | 2 |
| GALC protein | Homo sapiens (human) | Potency | 2.5146 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Potency | 19.3434 | 1 | 46 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Potency | 19.3434 | 1 | 46 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Potency | 19.3434 | 1 | 46 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 19.3434 | 1 | 46 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Potency | 19.3434 | 1 | 46 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Potency | 19.3434 | 1 | 46 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Potency | 19.3434 | 1 | 46 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 19.3434 | 1 | 46 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Potency | 19.3434 | 1 | 46 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Potency | 19.3434 | 1 | 46 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Potency | 19.3434 | 1 | 46 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Potency | 19.3434 | 1 | 46 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Potency | 19.3434 | 1 | 46 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Potency | 19.3434 | 1 | 46 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Potency | 19.3434 | 1 | 46 |
| geminin | Homo sapiens (human) | Potency | 12.8293 | 5 | 82 |
| GLI family zinc finger 3 | Homo sapiens (human) | Potency | 22.1681 | 3 | 97 |
| glp-1 receptor, partial | Homo sapiens (human) | Potency | 14.5593 | 1 | 11 |
| GLS protein | Homo sapiens (human) | Potency | 9.9921 | 2 | 37 |
| glucocerebrosidase | Homo sapiens (human) | Potency | 27.3978 | 1 | 20 |
| glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 25.4172 | 5 | 88 |
| glucokinase regulatory protein | Homo sapiens (human) | Potency | 16.0738 | 2 | 4 |
| Glutamate receptor 1 | Rattus norvegicus (Norway rat) | Potency | 2.1540 | 1 | 4 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | Potency | 22.8403 | 2 | 29 |
| Glutamate receptor 3 | Rattus norvegicus (Norway rat) | Potency | 2.1540 | 1 | 4 |
| Glutamate receptor 4 | Rattus norvegicus (Norway rat) | Potency | 2.1540 | 1 | 4 |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| glyceraldehyde-3-phosphate dehydrogenase isoform 1 | Homo sapiens (human) | Potency | 52.2758 | 1 | 2 |
| Glycoprotein hormones alpha chain | Homo sapiens (human) | Potency | 7.1207 | 1 | 3 |
| GTP-binding nuclear protein Ran isoform 1 | Homo sapiens (human) | Potency | 22.5914 | 1 | 8 |
| Guanine nucleotide-binding protein G | Homo sapiens (human) | Potency | 22.4842 | 2 | 12 |
| guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1 | Homo sapiens (human) | Potency | 11.2947 | 1 | 2 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | Homo sapiens (human) | Potency | 21.2393 | 2 | 18 |
| heat shock protein beta-1 | Homo sapiens (human) | Potency | 43.4307 | 2 | 42 |
| hemoglobin subunit beta | Homo sapiens (human) | Potency | 25.1291 | 3 | 5 |
| hexokinase-4 isoform 1 | Homo sapiens (human) | Potency | 16.0738 | 2 | 4 |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | Potency | 12.3618 | 2 | 109 |
| histone acetyltransferase KAT2A isoform 1 | Homo sapiens (human) | Potency | 23.3410 | 1 | 24 |
| histone deacetylase 9 isoform 3 | Homo sapiens (human) | Potency | 19.3420 | 2 | 24 |
| Histone H2A.x | Cricetulus griseus (Chinese hamster) | Potency | 51.2813 | 2 | 60 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | Homo sapiens (human) | Potency | 31.6269 | 1 | 11 |
| HLA class I histocompatibility antigen, B alpha chain | Homo sapiens (human) | Potency | 12.3069 | 1 | 15 |
| huntingtin isoform 2 | Homo sapiens (human) | Potency | 21.1486 | 2 | 5 |
| hypothetical protein, conserved | Trypanosoma brucei | Potency | 21.2480 | 4 | 21 |
| hypoxia-inducible factor 1 alpha subunit | Homo sapiens (human) | Potency | 48.7460 | 2 | 35 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Homo sapiens (human) | Potency | 8.5465 | 3 | 33 |
| IDH1 | Homo sapiens (human) | Potency | 19.8175 | 1 | 14 |
| importin subunit beta-1 isoform 1 | Homo sapiens (human) | Potency | 38.3772 | 2 | 20 |
| Inositol hexakisphosphate kinase 1 | Homo sapiens (human) | Potency | 12.3069 | 1 | 30 |
| Inositol monophosphatase 1 | Rattus norvegicus (Norway rat) | Potency | 12.8371 | 2 | 23 |
| Integrin alpha-IIb | Homo sapiens (human) | Potency | 16.5839 | 1 | 14 |
| Integrin beta-3 | Homo sapiens (human) | Potency | 16.5839 | 1 | 14 |
| Interferon beta | Homo sapiens (human) | Potency | 17.4446 | 3 | 47 |
| interleukin 8 | Homo sapiens (human) | Potency | 66.5662 | 1 | 9 |
| isocitrate dehydrogenase 1, partial | Homo sapiens (human) | Potency | 48.3387 | 1 | 5 |
| lamin isoform A-delta10 | Homo sapiens (human) | Potency | 11.5231 | 2 | 36 |
| lethal factor (plasmid) | Bacillus anthracis str. A2012 | Potency | 11.0623 | 2 | 19 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | Homo sapiens (human) | Potency | 18.3419 | 2 | 9 |
| Luciferase | Photinus pyralis (common eastern firefly) | Potency | 29.3612 | 4 | 59 |
| luciferase | Photuris pensylvanica (Pennsylania firefly) | Potency | 16.7324 | 3 | 6 |
| luteinizing hormone receptor | Homo sapiens (human) | Potency | 84.9214 | 1 | 1 |
| lysosomal alpha-glucosidase preproprotein | Homo sapiens (human) | Potency | 19.7741 | 4 | 22 |
| M-phase phosphoprotein 8 | Homo sapiens (human) | Potency | 23.4122 | 1 | 19 |
| Microtubule-associated protein tau | Homo sapiens (human) | Potency | 15.7758 | 2 | 130 |
| mitogen-activated protein kinase 1 | Homo sapiens (human) | Potency | 22.2333 | 3 | 26 |
| muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | Potency | 9.8154 | 2 | 10 |
| muscleblind-like protein 1 isoform 1 | Homo sapiens (human) | Potency | 22.5181 | 3 | 17 |
| Neuronal acetylcholine receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 33.5520 | 1 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 33.5520 | 1 | 2 |
| neuropeptide S receptor isoform A | Homo sapiens (human) | Potency | 9.3103 | 3 | 9 |
| NFKB1 protein, partial | Homo sapiens (human) | Potency | 8.6211 | 2 | 22 |
| nonstructural protein 1 | Influenza A virus (A/WSN/1933(H1N1)) | Potency | 17.9021 | 1 | 11 |
| NPC intracellular cholesterol transporter 1 precursor | Homo sapiens (human) | Potency | 19.1721 | 1 | 7 |
| Nrf2 | Homo sapiens (human) | Potency | 19.4452 | 2 | 7 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 28.1585 | 4 | 107 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | Homo sapiens (human) | Potency | 8.9210 | 1 | 8 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | Homo sapiens (human) | Potency | 35.3380 | 1 | 5 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 42.6245 | 2 | 33 |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | Potency | 27.7409 | 1 | 9 |
| nuclear receptor ROR-gamma isoform 1 | Mus musculus (house mouse) | Potency | 18.4443 | 4 | 73 |
| nuclear receptor subfamily 1, group I, member 2 | Rattus norvegicus (Norway rat) | Potency | 18.3667 | 1 | 5 |
| nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 31.4629 | 3 | 89 |
| Ornithine decarboxylase | Rattus norvegicus (Norway rat) | Potency | 5.0032 | 1 | 2 |
| P53 | Homo sapiens (human) | Potency | 38.9416 | 1 | 5 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | Homo sapiens (human) | Potency | 52.0194 | 1 | 16 |
| Parkin | Homo sapiens (human) | Potency | 24.7623 | 3 | 12 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | Potency | 44.6276 | 2 | 20 |
| peripheral myelin protein 22 | Rattus norvegicus (Norway rat) | Potency | 14.0890 | 2 | 20 |
| peripheral myelin protein 22 isoform 1 | Homo sapiens (human) | Potency | 56.0911 | 1 | 11 |
| peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 28.8779 | 5 | 71 |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | Potency | 36.9244 | 1 | 3 |
| peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 31.2158 | 5 | 58 |
| phosphoglycerate kinase | Trypanosoma brucei brucei TREU927 | Potency | 7.9941 | 3 | 10 |
| phosphopantetheinyl transferase | Bacillus subtilis | Potency | 45.6658 | 3 | 54 |
| PINK1 | Homo sapiens (human) | Potency | 42.7696 | 1 | 4 |
| plasminogen precursor | Mus musculus (house mouse) | Potency | 8.9653 | 2 | 19 |
| polyprotein | Zika virus | Potency | 21.2382 | 1 | 7 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | Homo sapiens (human) | Potency | 10.2143 | 1 | 14 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) | Potency | 9.5914 | 1 | 23 |
| potassium voltage-gated channel subfamily H member 2 isoform d | Homo sapiens (human) | Potency | 17.8278 | 1 | 9 |
| PPM1D protein | Homo sapiens (human) | Potency | 20.0555 | 1 | 20 |
| pregnane X nuclear receptor | Homo sapiens (human) | Potency | 37.8082 | 3 | 56 |
| pregnane X receptor | Rattus norvegicus (Norway rat) | Potency | 33.7915 | 1 | 10 |
| progesterone receptor | Homo sapiens (human) | Potency | 35.4129 | 3 | 42 |
| pyruvate kinase | Leishmania mexicana mexicana | Potency | 14.5320 | 5 | 13 |
| pyruvate kinase PKM isoform a | Homo sapiens (human) | Potency | 13.5074 | 4 | 8 |
| pyruvate kinase PKM isoform b | Homo sapiens (human) | Potency | 5.0032 | 2 | 4 |
| Rap guanine nucleotide exchange factor 3 | Homo sapiens (human) | Potency | 23.3328 | 2 | 10 |
| Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) | Potency | 25.1702 | 1 | 6 |
| RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 19.4411 | 2 | 76 |
| ras-related protein Rab-9A | Homo sapiens (human) | Potency | 35.2445 | 1 | 9 |
| regulator of G-protein signaling 4 | Homo sapiens (human) | Potency | 15.7476 | 1 | 24 |
| retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 30.3320 | 3 | 116 |
| retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 21.0873 | 4 | 91 |
| RGS12 | Homo sapiens (human) | Potency | 11.2947 | 1 | 2 |
| runt-related transcription factor 1 isoform AML1b | Homo sapiens (human) | Potency | 0.3604 | 2 | 2 |
| serine-protein kinase ATM isoform a | Homo sapiens (human) | Potency | 18.4163 | 4 | 11 |
| serine/threonine-protein kinase mTOR isoform 1 | Homo sapiens (human) | Potency | 15.2040 | 4 | 17 |
| serine/threonine-protein kinase PLK1 | Homo sapiens (human) | Potency | 15.9366 | 1 | 7 |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | Potency | 5.7988 | 1 | 1 |
| signal transducer and activator of transcription 6, interleukin-4 induced | Homo sapiens (human) | Potency | 2.5119 | 2 | 2 |
| Single-stranded DNA cytosine deaminase | Homo sapiens (human) | Potency | 15.8489 | 1 | 3 |
| SMAD family member 2 | Homo sapiens (human) | Potency | 26.4986 | 3 | 23 |
| SMAD family member 3 | Homo sapiens (human) | Potency | 26.4986 | 3 | 23 |
| Smad3 | Homo sapiens (human) | Potency | 20.9080 | 1 | 17 |
| snurportin-1 | Homo sapiens (human) | Potency | 38.3772 | 2 | 20 |
| Sodium channel protein type 1 subunit alpha | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Sodium channel protein type 2 subunit alpha | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Sodium channel protein type 3 subunit alpha | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | Potency | 20.4068 | 1 | 10 |
| survival motor neuron protein isoform d | Homo sapiens (human) | Potency | 15.8288 | 1 | 33 |
| T cell receptor, partial | Homo sapiens (human) | Potency | 6.2841 | 1 | 1 |
| TAR DNA-binding protein 43 | Homo sapiens (human) | Potency | 14.7968 | 1 | 6 |
| TDP1 protein | Homo sapiens (human) | Potency | 17.1375 | 2 | 187 |
| thioredoxin glutathione reductase | Schistosoma mansoni | Potency | 27.0720 | 1 | 15 |
| thioredoxin reductase | Rattus norvegicus (Norway rat) | Potency | 29.1698 | 4 | 56 |
| Thrombopoietin | Homo sapiens (human) | Potency | 8.8533 | 2 | 18 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 28.2512 | 3 | 98 |
| thyroid hormone receptor beta isoform a | Homo sapiens (human) | Potency | 42.4543 | 4 | 26 |
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 29.3742 | 7 | 84 |
| thyrotropin-releasing hormone receptor | Homo sapiens (human) | Potency | 24.1179 | 2 | 10 |
| transcriptional regulator ERG isoform 3 | Homo sapiens (human) | Potency | 26.6514 | 1 | 2 |
| transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | Potency | 31.6228 | 1 | 1 |
| TSHR protein | Homo sapiens (human) | Potency | 15.5035 | 2 | 2 |
| tumor necrosis factor | Homo sapiens (human) | Potency | 53.0804 | 1 | 1 |
| tumor susceptibility gene 101 protein | Homo sapiens (human) | Potency | 50.1187 | 1 | 1 |
| tyrosine-protein kinase Yes | Homo sapiens (human) | Potency | 15.4103 | 1 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | Homo sapiens (human) | Potency | 10.8540 | 3 | 8 |
| urokinase plasminogen activator surface receptor precursor | Mus musculus (house mouse) | Potency | 8.9653 | 2 | 19 |
| urokinase-type plasminogen activator precursor | Mus musculus (house mouse) | Potency | 8.9653 | 2 | 19 |
| USP1 protein, partial | Homo sapiens (human) | Potency | 45.5814 | 2 | 32 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 31.6610 | 2 | 45 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 23.8286 | 5 | 48 |
| vitamin D3 receptor isoform VDRA | Homo sapiens (human) | Potency | 37.2247 | 5 | 39 |
| Voltage-dependent calcium channel gamma-2 subunit | Mus musculus (house mouse) | Potency | 26.1501 | 1 | 25 |
| Vpr | Human immunodeficiency virus 1 | Potency | 26.8613 | 1 | 3 |
| WRN | Homo sapiens (human) | Potency | 35.0023 | 1 | 6 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | Homo sapiens (human) | IC50 | 2.2555 | 2 | 2 |
| 1-deoxy-D-xylulose 5-phosphate reductoisomerase | Escherichia coli K-12 | IC50 | 2.2750 | 1 | 4 |
| 10 kDa chaperonin | Escherichia coli | IC50 | 20.0425 | 2 | 8 |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | IC50 | 29.6500 | 1 | 4 |
| 14-3-3 protein gamma | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| 17-beta-hydroxysteroid dehydrogenase type 1 | Homo sapiens (human) | IC50 | 5.5000 | 1 | 1 |
| 17-beta-hydroxysteroid dehydrogenase type 2 | Homo sapiens (human) | IC50 | 2.6900 | 2 | 4 |
| 2-5A-dependent ribonuclease | Homo sapiens (human) | IC50 | 264.0000 | 1 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | IC50 | 8.9000 | 1 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Rattus norvegicus (Norway rat) | IC50 | 10.5500 | 1 | 1 |
| 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ | Yersinia pseudotuberculosis YPIII | IC50 | 6.9000 | 1 | 2 |
| 3-oxoacyl- | Pseudomonas aeruginosa | IC50 | 27.0000 | 1 | 1 |
| 3-oxoacyl-[acyl-carrier-protein] reductase | Plasmodium falciparum 3D7 | IC50 | 0.3200 | 1 | 1 |
| 3-oxoacyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 6.0167 | 1 | 6 |
| 4-aminobutyrate aminotransferase, mitochondrial | Homo sapiens (human) | IC50 | 6,408.5500 | 2 | 2 |
| 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | Homo sapiens (human) | IC50 | 36.7840 | 1 | 15 |
| 4-hydroxyphenylpyruvate dioxygenase | Arabidopsis thaliana (thale cress) | IC50 | 73.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | IC50 | 0.5000 | 1 | 1 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | IC50 | 12.5000 | 2 | 2 |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | Ki | 0.0032 | 1 | 1 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | Ki | 0.4035 | 6 | 7 |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | IC50 | 1.1970 | 1 | 1 |
| 5-hydroxytryptamine receptor 1B | Homo sapiens (human) | Ki | 0.0035 | 1 | 1 |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | Ki | 0.2015 | 3 | 4 |
| 5-hydroxytryptamine receptor 1D | Homo sapiens (human) | Ki | 0.0054 | 1 | 1 |
| 5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | Ki | 0.0020 | 1 | 1 |
| 5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | Ki | 0.0020 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | IC50 | 21.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | Ki | 0.1524 | 2 | 2 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | Ki | 0.5571 | 7 | 7 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | IC50 | 0.6040 | 1 | 3 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | Ki | 0.3843 | 1 | 3 |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | Ki | 0.5571 | 7 | 7 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | Ki | 0.0450 | 1 | 1 |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | Ki | 0.5500 | 8 | 8 |
| 5-hydroxytryptamine receptor 4 | Homo sapiens (human) | Ki | 0.1362 | 2 | 2 |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | Ki | 0.0690 | 2 | 2 |
| 5-hydroxytryptamine receptor 7 | Homo sapiens (human) | IC50 | 275.0000 | 1 | 2 |
| 5-hydroxytryptamine receptor 7 | Homo sapiens (human) | Ki | 0.0035 | 2 | 2 |
| 5-hydroxytryptamine receptor 7 | Rattus norvegicus (Norway rat) | Ki | 0.0009 | 1 | 1 |
| 5-lipoxygenase | Bos taurus (cattle) | IC50 | 0.7000 | 2 | 2 |
| 5'-nucleotidase | Homo sapiens (human) | IC50 | 1.8500 | 1 | 1 |
| 5'-nucleotidase | Mus musculus (house mouse) | IC50 | 0.0400 | 1 | 1 |
| 5'-nucleotidase | Rattus norvegicus (Norway rat) | Ki | 0.0453 | 1 | 1 |
| 6-phosphogluconate dehydrogenase, decarboxylating | Homo sapiens (human) | IC50 | 666.9067 | 1 | 3 |
| 60 kDa chaperonin | Escherichia coli K-12 | IC50 | 250.0000 | 1 | 4 |
| 60 kDa chaperonin | Escherichia coli | IC50 | 20.0425 | 2 | 8 |
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | IC50 | 29.6500 | 1 | 4 |
| 7,8-dihydro-8-oxoguanine triphosphatase | Homo sapiens (human) | IC50 | 0.4700 | 1 | 1 |
| 72 kDa type IV collagenase | Homo sapiens (human) | IC50 | 32.0874 | 5 | 19 |
| 90-kda heat shock protein beta HSP90 beta, partial | Homo sapiens (human) | IC50 | 16.3116 | 2 | 2 |
| acetyl-CoA acetyltransferase/HMG-CoA reductase | Enterococcus faecalis | IC50 | 1,265.3900 | 1 | 1 |
| Acetylcholinesterase | Electrophorus electricus (electric eel) | IC50 | 149.1278 | 10 | 10 |
| Acetylcholinesterase | Homo sapiens (human) | IC50 | 888.7000 | 8 | 9 |
| Acetylcholinesterase | Electrophorus electricus (electric eel) | Ki | 50.0006 | 2 | 2 |
| Acetylcholinesterase | Homo sapiens (human) | Ki | 119.0750 | 1 | 4 |
| Acyl carrier protein, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | IC50 | 3,955.0000 | 1 | 2 |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | Ki | 9.4083 | 3 | 12 |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | IC50 | 3,955.0000 | 1 | 2 |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | Ki | 6.9275 | 2 | 8 |
| Adenosine receptor A3 | Homo sapiens (human) | IC50 | 5.2415 | 1 | 2 |
| Adenosine receptor A3 | Homo sapiens (human) | Ki | 17.4812 | 3 | 4 |
| Adenylate cyclase | Arthrospira platensis | IC50 | 100.0000 | 1 | 1 |
| ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 | Homo sapiens (human) | IC50 | 42.3333 | 1 | 6 |
| Albumin | Bos taurus (cattle) | IC50 | 41.9000 | 1 | 1 |
| albumin precursor | Bos taurus (cattle) | IC50 | 94.2660 | 1 | 1 |
| Alcohol dehydrogenase E chain | Equus caballus (horse) | Ki | 42,000.0000 | 1 | 1 |
| Alcohol dehydrogenase S chain | Equus caballus (horse) | Ki | 42,000.0000 | 1 | 1 |
| Aldehyde oxidase 1 | Cavia porcellus (domestic guinea pig) | Ki | 4.5300 | 1 | 1 |
| Aldo-keto reductase family 1 member A1 | Homo sapiens (human) | IC50 | 16.3500 | 4 | 4 |
| Aldo-keto reductase family 1 member A1 | Rattus norvegicus (Norway rat) | IC50 | 1.3630 | 2 | 3 |
| Aldo-keto reductase family 1 member A1 | Sus scrofa (pig) | IC50 | 14.7667 | 3 | 3 |
| Aldo-keto reductase family 1 member B1 | Bos taurus (cattle) | IC50 | 6.7005 | 17 | 19 |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | IC50 | 82.5102 | 39 | 51 |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | IC50 | 6.7653 | 33 | 45 |
| Aldo-keto reductase family 1 member B1 | Sus scrofa (pig) | IC50 | 22.4000 | 2 | 3 |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | Ki | 0.9500 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | Ki | 2.2763 | 1 | 3 |
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | IC50 | 1.8800 | 6 | 6 |
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | Ki | 0.0460 | 1 | 1 |
| Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | IC50 | 14.6800 | 3 | 3 |
| Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | IC50 | 9.3102 | 5 | 5 |
| Aldo-keto reductase family 1 member C21 | Mus musculus (house mouse) | IC50 | 17.5000 | 1 | 3 |
| Aldo-keto reductase family 1 member C21 | Mus musculus (house mouse) | Ki | 11.0000 | 1 | 1 |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | IC50 | 3.0336 | 6 | 6 |
| Aldo-keto reductase family 1 member C4 | Homo sapiens (human) | IC50 | 5.2750 | 2 | 2 |
| ALK tyrosine kinase receptor | Homo sapiens (human) | IC50 | 21.6600 | 2 | 2 |
| alkaline phosphatase, germ cell type preproprotein | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| alkaline phosphatase, intestinal | Homo sapiens (human) | IC50 | 7.1050 | 2 | 2 |
| alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | Homo sapiens (human) | IC50 | 15.8690 | 1 | 3 |
| Alpha-(1,3)-fucosyltransferase 7 | Homo sapiens (human) | IC50 | 36.7840 | 1 | 15 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 3.6610 | 2 | 3 |
| Alpha-1A adrenergic receptor | Bos taurus (cattle) | Ki | 1.1002 | 1 | 2 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 1.5658 | 2 | 8 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 13.8376 | 3 | 7 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 1.5658 | 2 | 8 |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 0.5000 | 1 | 1 |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 1.1002 | 1 | 6 |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | Ki | 9.3400 | 1 | 1 |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | Ki | 9.6370 | 1 | 1 |
| Alpha-amylase 1A | Homo sapiens (human) | IC50 | 173.6444 | 3 | 9 |
| Alpha-glucosidase MAL12 | Saccharomyces cerevisiae S288C | IC50 | 251.4000 | 1 | 1 |
| Alpha-glucosidase MAL12 | Saccharomyces cerevisiae S288C | Ki | 21.5000 | 1 | 1 |
| Alpha-synuclein | Homo sapiens (human) | IC50 | 7.9887 | 5 | 15 |
| Amine oxidase [flavin-containing] | Danio rerio (zebrafish) | Ki | 30.8000 | 1 | 1 |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | IC50 | 21.2274 | 10 | 12 |
| Amine oxidase [flavin-containing] A | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | Ki | 10.5000 | 1 | 1 |
| Amine oxidase [flavin-containing] A | Bos taurus (cattle) | IC50 | 0.0100 | 1 | 1 |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | Ki | 4.8000 | 1 | 1 |
| Amine oxidase [flavin-containing] B | Bos taurus (cattle) | IC50 | 20.0000 | 1 | 1 |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | IC50 | 34.6110 | 9 | 10 |
| Amine oxidase [flavin-containing] B | Mus musculus (house mouse) | IC50 | 0.3000 | 2 | 2 |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | IC50 | 0.0700 | 1 | 5 |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | Ki | 6.3000 | 2 | 2 |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | Ki | 6.9000 | 2 | 2 |
| Amyloid-beta precursor protein | Homo sapiens (human) | IC50 | 46.5800 | 32 | 40 |
| Androgen receptor | Homo sapiens (human) | IC50 | 57.5955 | 6 | 7 |
| Androgen receptor | Rattus norvegicus (Norway rat) | IC50 | 94.0150 | 2 | 5 |
| Androgen receptor | Homo sapiens (human) | Ki | 0.0029 | 5 | 5 |
| Androgen receptor | Rattus norvegicus (Norway rat) | Ki | 0.0048 | 1 | 1 |
| Angiopoietin-1 receptor | Homo sapiens (human) | IC50 | 0.2600 | 1 | 1 |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | IC50 | 121,901.7883 | 3 | 6 |
| Angiotensin-converting enzyme | Homo sapiens (human) | IC50 | 5,466.6667 | 1 | 3 |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | IC50 | 5.3350 | 2 | 2 |
| Anthrax toxin receptor 2 | Homo sapiens (human) | IC50 | 300.0000 | 1 | 8 |
| Apoptosis regulator Bcl-2 | Homo sapiens (human) | IC50 | 0.4500 | 1 | 1 |
| Apoptosis regulator Bcl-2 | Homo sapiens (human) | Ki | 50.1811 | 2 | 4 |
| Apoptotic peptidase activating factor 1 | Homo sapiens (human) | IC50 | 57.7500 | 2 | 2 |
| Arachidonate 5-lipoxygenase-activating protein | Homo sapiens (human) | Ki | 0.1170 | 1 | 1 |
| Arginase | Leishmania amazonensis | IC50 | 3.9333 | 1 | 6 |
| Arginase | Leishmania amazonensis | Ki | 2.4750 | 1 | 4 |
| Arginase-1 | Bos taurus (cattle) | IC50 | 285.0000 | 1 | 1 |
| Aromatase | Homo sapiens (human) | IC50 | 17.2523 | 12 | 15 |
| Aromatase | Homo sapiens (human) | Ki | 22.1350 | 2 | 2 |
| Arrestin, beta 1 | Homo sapiens (human) | IC50 | 1.5240 | 1 | 1 |
| Aryl hydrocarbon receptor | Oryctolagus cuniculus (rabbit) | Ki | 0.3743 | 2 | 3 |
| ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | IC50 | 118.4286 | 1 | 7 |
| ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | IC50 | 1.2850 | 1 | 1 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | IC50 | 32.6245 | 5 | 6 |
| ATP-sensitive inward rectifier potassium channel 11 | Homo sapiens (human) | IC50 | 1.2850 | 1 | 1 |
| Aurora kinase A | Homo sapiens (human) | IC50 | 2.4800 | 1 | 1 |
| Aurora kinase B | Homo sapiens (human) | IC50 | 6.8000 | 3 | 15 |
| Autoinducer 2-binding periplasmic protein LuxP | Vibrio harveyi | IC50 | 50.0000 | 1 | 1 |
| B-cell CLL/lymphoma 9 protein | Homo sapiens (human) | IC50 | 5.2130 | 1 | 1 |
| B-cell CLL/lymphoma 9 protein | Homo sapiens (human) | Ki | 4.8780 | 3 | 3 |
| B2 bradykinin receptor | Cavia porcellus (domestic guinea pig) | IC50 | 4.0000 | 2 | 2 |
| Bcl-2-like protein 1 | Homo sapiens (human) | IC50 | 95.2950 | 2 | 2 |
| Bcl-2-like protein 10 | Homo sapiens (human) | IC50 | 0.3600 | 1 | 1 |
| Bcl-2-like protein 2 | Homo sapiens (human) | IC50 | 2.3300 | 1 | 1 |
| Bcl-2-related protein A1 | Homo sapiens (human) | IC50 | 1.7900 | 1 | 1 |
| Bcl2-associated agonist of cell death | Homo sapiens (human) | Ki | 0.4900 | 1 | 1 |
| Beta-carbonic anhydrase 1 | Mycobacterium tuberculosis H37Rv | Ki | 36.2540 | 4 | 10 |
| Beta-glucuronidase | Homo sapiens (human) | IC50 | 38.0000 | 1 | 1 |
| Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 2.3217 | 2 | 6 |
| Beta-lactamase | Enterobacter cloacae | IC50 | 327.2500 | 3 | 4 |
| Beta-lactamase | Escherichia coli K-12 | IC50 | 58.0000 | 4 | 4 |
| Beta-secretase 1 | Homo sapiens (human) | IC50 | 53.0851 | 14 | 19 |
| Beta-secretase 1 | Homo sapiens (human) | Ki | 9.0500 | 2 | 4 |
| BH3-interacting domain death agonist | Homo sapiens (human) | IC50 | 1.0733 | 6 | 6 |
| Bifunctional epoxide hydrolase 2 | Homo sapiens (human) | IC50 | 15.5018 | 7 | 11 |
| Bifunctional epoxide hydrolase 2 | Homo sapiens (human) | Ki | 39.6000 | 1 | 1 |
| Bile salt export pump | Homo sapiens (human) | IC50 | 114.5700 | 8 | 20 |
| Bile salt export pump | Rattus norvegicus (Norway rat) | IC50 | 7.2500 | 2 | 2 |
| Breakpoint cluster region protein | Homo sapiens (human) | IC50 | 19.0000 | 1 | 2 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | IC50 | 11.6262 | 4 | 8 |
| Butyrophilin subfamily 3 member A1 | Homo sapiens (human) | IC50 | 513.0000 | 1 | 1 |
| C-C chemokine receptor type 4 | Homo sapiens (human) | IC50 | 47.2409 | 3 | 6 |
| C-X-C chemokine receptor type 1 | Homo sapiens (human) | IC50 | 35.3780 | 2 | 4 |
| Cadherin-1 | Homo sapiens (human) | Ki | 387.2000 | 1 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | Bos taurus (cattle) | IC50 | 500.0000 | 1 | 2 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | Bos taurus (cattle) | IC50 | 500.0000 | 1 | 2 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | Rattus norvegicus (Norway rat) | IC50 | 275.0000 | 1 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | Rattus norvegicus (Norway rat) | IC50 | 275.0000 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit beta | Homo sapiens (human) | IC50 | 3.0000 | 1 | 1 |
| Calmodulin-1 | Homo sapiens (human) | IC50 | 23.2000 | 1 | 2 |
| cAMP-dependent protein kinase catalytic subunit alpha | Bos taurus (cattle) | IC50 | 0.6000 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | IC50 | 2.0500 | 2 | 2 |
| cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | IC50 | 2.0500 | 2 | 2 |
| cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | IC50 | 2.0500 | 2 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Rattus norvegicus (Norway rat) | IC50 | 6.5900 | 1 | 4 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Rattus norvegicus (Norway rat) | IC50 | 6.5900 | 1 | 4 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Rattus norvegicus (Norway rat) | IC50 | 6.5900 | 1 | 4 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | IC50 | 1.3100 | 1 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Rattus norvegicus (Norway rat) | IC50 | 6.5900 | 1 | 4 |
| Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | IC50 | 102.2222 | 2 | 9 |
| Canalicular multispecific organic anion transporter 1 | Rattus norvegicus (Norway rat) | Ki | 7.9500 | 1 | 1 |
| Cannabinoid receptor 1 | Homo sapiens (human) | IC50 | 3.3100 | 1 | 1 |
| Cannabinoid receptor 1 | Mus musculus (house mouse) | IC50 | 1,000.0000 | 1 | 2 |
| Cannabinoid receptor 1 | Homo sapiens (human) | Ki | 17.8595 | 5 | 6 |
| Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | Ki | 11.5200 | 2 | 2 |
| Cannabinoid receptor 2 | Homo sapiens (human) | IC50 | 3.4600 | 1 | 1 |
| Cannabinoid receptor 2 | Homo sapiens (human) | Ki | 68.1755 | 5 | 6 |
| Carbonic anhydrase | Candida albicans SC5314 | Ki | 0.9728 | 4 | 6 |
| Carbonic anhydrase | Dicentrarchus labrax (European seabass) | Ki | 5.0300 | 1 | 2 |
| Carbonic anhydrase | Helicobacter pylori 26695 | Ki | 0.2245 | 2 | 2 |
| Carbonic anhydrase | Saccharomyces cerevisiae S288C | Ki | 0.1060 | 1 | 1 |
| Carbonic anhydrase | Stylophora pistillata | Ki | 0.6450 | 1 | 1 |
| Carbonic anhydrase | Anopheles gambiae (African malaria mosquito) | Ki | 0.2630 | 1 | 1 |
| Carbonic anhydrase | Astrosclera willeyana | Ki | 0.1650 | 1 | 1 |
| Carbonic anhydrase | Cryptococcus neoformans var. grubii | Ki | 1.0070 | 2 | 3 |
| Carbonic anhydrase | Mycobacterium tuberculosis H37Rv | Ki | 6.1550 | 1 | 2 |
| Carbonic anhydrase | Nakaseomyces glabratus CBS 138 | Ki | 0.1140 | 1 | 1 |
| Carbonic anhydrase | Stylophora pistillata | Ki | 0.2590 | 2 | 2 |
| Carbonic anhydrase | Sulfurihydrogenibium sp. YO3AOP1 | Ki | 0.1400 | 1 | 1 |
| Carbonic anhydrase 1 | Homo sapiens (human) | IC50 | 1.8600 | 1 | 1 |
| Carbonic anhydrase 1 | Homo sapiens (human) | Ki | 62.7124 | 71 | 148 |
| Carbonic anhydrase 12 | Homo sapiens (human) | IC50 | 1.8600 | 1 | 1 |
| Carbonic anhydrase 12 | Homo sapiens (human) | Ki | 110.5894 | 21 | 55 |
| Carbonic anhydrase 13 | Homo sapiens (human) | IC50 | 1.8600 | 1 | 1 |
| Carbonic anhydrase 13 | Homo sapiens (human) | Ki | 172.0718 | 5 | 19 |
| Carbonic anhydrase 13 | Mus musculus (house mouse) | Ki | 88.9990 | 5 | 20 |
| Carbonic anhydrase 14 | Homo sapiens (human) | IC50 | 1.8600 | 1 | 1 |
| Carbonic anhydrase 14 | Homo sapiens (human) | Ki | 115.9527 | 14 | 43 |
| Carbonic anhydrase 15 | Mus musculus (house mouse) | Ki | 122.0579 | 7 | 9 |
| Carbonic anhydrase 2 | Bos taurus (cattle) | IC50 | 1.8600 | 1 | 1 |
| Carbonic anhydrase 2 | Homo sapiens (human) | IC50 | 3.0900 | 3 | 3 |
| Carbonic anhydrase 2 | Homo sapiens (human) | Ki | 50.5067 | 83 | 161 |
| Carbonic anhydrase 2 | Mycobacterium tuberculosis H37Rv | Ki | 2.6294 | 2 | 7 |
| Carbonic anhydrase 3 | Homo sapiens (human) | IC50 | 1.8600 | 1 | 1 |
| Carbonic anhydrase 3 | Bos taurus (cattle) | Ki | 8.8383 | 3 | 23 |
| Carbonic anhydrase 3 | Homo sapiens (human) | Ki | 256.7661 | 9 | 37 |
| Carbonic anhydrase 4 | Homo sapiens (human) | IC50 | 1.8600 | 1 | 1 |
| Carbonic anhydrase 4 | Homo sapiens (human) | Ki | 67.8233 | 15 | 72 |
| Carbonic anhydrase 5A, mitochondrial | Homo sapiens (human) | IC50 | 5.3600 | 2 | 2 |
| Carbonic anhydrase 5A, mitochondrial | Homo sapiens (human) | Ki | 120.4948 | 13 | 41 |
| Carbonic anhydrase 5B, mitochondrial | Homo sapiens (human) | IC50 | 1.8600 | 1 | 1 |
| Carbonic anhydrase 5B, mitochondrial | Homo sapiens (human) | Ki | 257.8914 | 13 | 41 |
| Carbonic anhydrase 6 | Homo sapiens (human) | IC50 | 1.8600 | 1 | 1 |
| Carbonic anhydrase 6 | Homo sapiens (human) | Ki | 103.0722 | 15 | 59 |
| Carbonic anhydrase 7 | Homo sapiens (human) | IC50 | 1.8600 | 1 | 1 |
| Carbonic anhydrase 7 | Homo sapiens (human) | Ki | 111.7234 | 19 | 52 |
| Carbonic anhydrase 9 | Homo sapiens (human) | IC50 | 5.6250 | 2 | 2 |
| Carbonic anhydrase 9 | Homo sapiens (human) | Ki | 104.4581 | 24 | 59 |
| Carbonic anhydrase, alpha family | Hydrogenovibrio crunogenus XCL-2 | Ki | 0.4110 | 1 | 1 |
| Carbonyl reductase [NADPH] 1 | Homo sapiens (human) | IC50 | 0.6700 | 1 | 1 |
| Carbonyl reductase [NADPH] 1 | Homo sapiens (human) | Ki | 0.1100 | 1 | 1 |
| Carboxylic ester hydrolase | Equus caballus (horse) | IC50 | 1,774.1000 | 1 | 1 |
| Casein kinase II subunit alpha | Homo sapiens (human) | IC50 | 2.7416 | 9 | 19 |
| Casein kinase II subunit alpha | Homo sapiens (human) | Ki | 2.2889 | 5 | 9 |
| Casein kinase II subunit alpha | Rattus norvegicus (Norway rat) | IC50 | 0.0400 | 1 | 1 |
| Casein kinase II subunit alpha 3 | Homo sapiens (human) | IC50 | 4.4286 | 2 | 7 |
| Casein kinase II subunit alpha 3 | Homo sapiens (human) | Ki | 4.4250 | 1 | 2 |
| Casein kinase II subunit alpha' | Homo sapiens (human) | IC50 | 2.8917 | 8 | 18 |
| Casein kinase II subunit alpha' | Homo sapiens (human) | Ki | 3.0067 | 2 | 3 |
| Casein kinase II subunit beta | Homo sapiens (human) | IC50 | 2.8917 | 8 | 18 |
| Casein kinase II subunit beta | Rattus norvegicus (Norway rat) | IC50 | 0.0400 | 1 | 1 |
| Casein kinase II subunit beta | Homo sapiens (human) | Ki | 3.0067 | 2 | 3 |
| Caspase-1 | Homo sapiens (human) | IC50 | 5.0400 | 1 | 3 |
| caspase-3 isoform a preproprotein | Homo sapiens (human) | IC50 | 17.0000 | 1 | 1 |
| caspase-9 isoform alpha precursor | Homo sapiens (human) | IC50 | 17.0000 | 1 | 1 |
| Catenin beta-1 | Homo sapiens (human) | IC50 | 5.2130 | 1 | 1 |
| Catenin beta-1 | Homo sapiens (human) | Ki | 4.8780 | 3 | 3 |
| Cathepsin D | Homo sapiens (human) | IC50 | 138.0000 | 1 | 1 |
| cathepsin L1 | Homo sapiens (human) | IC50 | 59.6420 | 1 | 2 |
| Cationic trypsin | Bos taurus (cattle) | IC50 | 34.7286 | 2 | 7 |
| Cellular retinoic acid-binding protein 1 | Gallus gallus (chicken) | IC50 | 0.5233 | 3 | 3 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | Rattus norvegicus (Norway rat) | IC50 | 81.3000 | 1 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | IC50 | 5.9000 | 1 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | Rattus norvegicus (Norway rat) | IC50 | 6.1000 | 1 | 1 |
| Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | Helicobacter pylori | Ki | 12.7000 | 1 | 3 |
| Chain A, APH(2')-Id | Enterococcus casseliflavus | Ki | 25.1000 | 1 | 1 |
| Chain A, Carbonic anhydrase 2 | Homo sapiens (human) | Ki | 0.0900 | 1 | 3 |
| Chain A, Casein kinase II subunit alpha | Homo sapiens (human) | Ki | 0.0200 | 1 | 1 |
| Chain A, Glycogen phosphorylase, muscle form | Oryctolagus cuniculus (rabbit) | Ki | 19.0100 | 1 | 2 |
| Chain A, Leukotriene A-4 hydrolase | Homo sapiens (human) | IC50 | 212.0000 | 1 | 17 |
| Chain A, Mitogen-activated protein kinase 8 | Homo sapiens (human) | IC50 | 4.6000 | 1 | 1 |
| Chain A, NAD-dependent deacetylase | Thermotoga maritima | IC50 | 1,000.0000 | 1 | 1 |
| Chain A, Nuclear Receptor ROR-beta | Rattus norvegicus (Norway rat) | Ki | 0.2800 | 1 | 1 |
| Chain A, Pancreatic alpha-amylase | Homo sapiens (human) | Ki | 110.0000 | 1 | 2 |
| Chain A, POLYMERASE PA | Influenza A virus | IC50 | 1.9000 | 1 | 1 |
| Chain A, Polymerase Pa | Influenza A virus (A/California/04/2009(H1N1)) | IC50 | 1.9000 | 1 | 4 |
| Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1 | Homo sapiens (human) | IC50 | 0.7800 | 1 | 4 |
| Chain A, RNA-directed RNA polymerase NS5 | Dengue virus 2 16681-PDK53 | IC50 | 35.0600 | 1 | 1 |
| Chain A, S-ADENOSYLMETHIONINE DECARBOXYLASE ALPHA CHAIN | Homo sapiens (human) | IC50 | 0.2001 | 1 | 4 |
| Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | Helicobacter pylori | Ki | 12.7000 | 1 | 3 |
| Chain B, Cell division protein kinase 6 | Homo sapiens (human) | IC50 | 0.8500 | 1 | 1 |
| Chain B, S-ADENOSYLMETHIONINE DECARBOXYLASE BETA CHAIN | Homo sapiens (human) | IC50 | 0.2001 | 1 | 4 |
| Chain E, Fibrin beta chain | Homo sapiens (human) | IC50 | 46.2655 | 2 | 2 |
| Cholecystokinin receptor type A | Homo sapiens (human) | Ki | 0.3020 | 1 | 1 |
| Cholinesterase | Equus caballus (horse) | IC50 | 80.9640 | 7 | 7 |
| Cholinesterase | Homo sapiens (human) | IC50 | 34.1975 | 4 | 4 |
| Cholinesterase | Equus caballus (horse) | Ki | 100.0000 | 1 | 1 |
| Chymotrypsin-C | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Chymotrypsin-like elastase family member 1 | Sus scrofa (pig) | IC50 | 28.7500 | 1 | 4 |
| Chymotrypsinogen A | Bos taurus (cattle) | IC50 | 361.6667 | 2 | 3 |
| Chymotrypsinogen B | Homo sapiens (human) | IC50 | 110.0000 | 1 | 2 |
| Class A sortase SrtA | Staphylococcus aureus | IC50 | 31.2600 | 3 | 3 |
| CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | Homo sapiens (human) | IC50 | 36.7840 | 1 | 15 |
| Coagulation factor VII | Homo sapiens (human) | IC50 | 80.0000 | 1 | 1 |
| Coagulation factor VII | Homo sapiens (human) | Ki | 8,000.0000 | 1 | 1 |
| Collagenase 3 | Homo sapiens (human) | IC50 | 8.4600 | 1 | 1 |
| Complex I intermediate-associated protein 30, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| core protein, partial | | IC50 | 35.9843 | 3 | 4 |
| CPG DNA methylase | Spiroplasma monobiae | Ki | 0.0280 | 1 | 1 |
| CREB-binding protein | Homo sapiens (human) | IC50 | 50.0000 | 2 | 2 |
| Cruzipain | Trypanosoma cruzi | IC50 | 91.5000 | 6 | 8 |
| Cyclic GMP-AMP synthase | Homo sapiens (human) | IC50 | 0.0040 | 1 | 1 |
| Cyclin homolog | Herpesvirus saimiri (strain 11) | IC50 | 12.5942 | 1 | 12 |
| Cyclin-A1 | Homo sapiens (human) | IC50 | 1.8850 | 2 | 2 |
| Cyclin-A2 | Homo sapiens (human) | IC50 | 1.8850 | 2 | 2 |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | IC50 | 16.1256 | 5 | 9 |
| Cyclin-dependent kinase 1 | Oryzias latipes (Japanese medaka) | IC50 | 12.5942 | 1 | 12 |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | IC50 | 12.1925 | 3 | 4 |
| Cyclin-dependent kinase 4 | Homo sapiens (human) | IC50 | 31.0450 | 2 | 2 |
| Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | IC50 | 11.1250 | 3 | 16 |
| Cyclin-dependent kinase 6 | Homo sapiens (human) | IC50 | 12.1987 | 2 | 15 |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | IC50 | 11.1250 | 3 | 16 |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | Ki | 0.1700 | 1 | 2 |
| Cystathionine beta-synthase | Homo sapiens (human) | IC50 | 18.8000 | 1 | 1 |
| Cysteine protease ATG4B | Homo sapiens (human) | IC50 | 4.2500 | 2 | 2 |
| Cytochrome c oxidase subunit NDUFA4 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| Cytochrome P450 11B1, mitochondrial | Rattus norvegicus (Norway rat) | IC50 | 43.3333 | 1 | 3 |
| Cytochrome P450 1A1 | Homo sapiens (human) | IC50 | 7.6729 | 10 | 16 |
| Cytochrome P450 1A1 | Homo sapiens (human) | Ki | 0.5030 | 2 | 7 |
| Cytochrome P450 1A2 | Homo sapiens (human) | IC50 | 7.3928 | 6 | 12 |
| Cytochrome P450 1A2 | Homo sapiens (human) | Ki | 4.7500 | 2 | 2 |
| Cytochrome P450 1B1 | Homo sapiens (human) | IC50 | 3.7478 | 11 | 18 |
| Cytochrome P450 1B1 | Homo sapiens (human) | Ki | 0.9537 | 7 | 15 |
| Cytochrome P450 2A6 | Homo sapiens (human) | IC50 | 25.0000 | 1 | 1 |
| Cytochrome P450 2B6 | Homo sapiens (human) | IC50 | 25.0000 | 1 | 1 |
| Cytochrome P450 2C19 | Homo sapiens (human) | IC50 | 1.9000 | 1 | 2 |
| Cytochrome P450 2C8 | Homo sapiens (human) | IC50 | 13.5000 | 2 | 2 |
| Cytochrome P450 2C9 | Homo sapiens (human) | IC50 | 16.7042 | 4 | 6 |
| Cytochrome P450 2C9 | Homo sapiens (human) | Ki | 18.1000 | 2 | 2 |
| Cytochrome P450 2D6 | Homo sapiens (human) | IC50 | 32.9617 | 6 | 6 |
| Cytochrome P450 2D6 | Homo sapiens (human) | Ki | 1.9500 | 1 | 1 |
| Cytochrome P450 2J2 | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Cytochrome P450 3A4 | Homo sapiens (human) | IC50 | 30.9500 | 9 | 10 |
| Cytochrome P450 3A4 | Homo sapiens (human) | Ki | 12.1500 | 2 | 2 |
| Cytochrome P450 3A5 | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
| Cytosol aminopeptidase | Sus scrofa (pig) | IC50 | 34.3000 | 1 | 1 |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | Ki | 6.0330 | 1 | 1 |
| D(3) dopamine receptor | Homo sapiens (human) | IC50 | 1.9290 | 1 | 1 |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | IC50 | 21.0000 | 1 | 1 |
| D(3) dopamine receptor | Homo sapiens (human) | Ki | 0.6550 | 1 | 1 |
| D(4) dopamine receptor | Homo sapiens (human) | Ki | 7.8460 | 1 | 1 |
| Death-associated protein kinase 1 | Homo sapiens (human) | IC50 | 114.3125 | 2 | 8 |
| Dehydrogenase/reductase SDR family member 9 | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
| Delta carbonic anhydrase | Conticribra weissflogii | Ki | 0.4040 | 1 | 1 |
| Delta-type opioid receptor | Mus musculus (house mouse) | IC50 | 7.6500 | 2 | 2 |
| Delta-type opioid receptor | Mus musculus (house mouse) | Ki | 0.0455 | 2 | 2 |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 0.0278 | 2 | 2 |
| Diacylglycerol lipase-alpha | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Dihydrolipoyl dehydrogenase | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 1,000.0000 | 1 | 1 |
| Dihydrolipoyl dehydrogenase, mitochondrial | Sus scrofa (pig) | IC50 | 1,000.0000 | 1 | 1 |
| Dihydroorotate dehydrogenase | Leishmania major | IC50 | 450.2105 | 1 | 14 |
| Dipeptidyl peptidase 3 | Homo sapiens (human) | IC50 | 76.7750 | 1 | 4 |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | IC50 | 72.8421 | 2 | 10 |
| Dipeptidyl peptidase 4 | Sus scrofa (pig) | IC50 | 0.4900 | 1 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) | IC50 | 110.5000 | 1 | 2 |
| DNA (cytosine-5)-methyltransferase 1 | Homo sapiens (human) | IC50 | 0.5000 | 1 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3A isoform a | Homo sapiens (human) | IC50 | 17.5000 | 1 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | IC50 | 9.3325 | 2 | 4 |
| DNA polymerase alpha catalytic subunit | Homo sapiens (human) | IC50 | 3.3000 | 1 | 1 |
| DNA polymerase beta | Homo sapiens (human) | IC50 | 26.3000 | 1 | 1 |
| DNA polymerase beta | Rattus norvegicus (Norway rat) | IC50 | 18.5000 | 1 | 1 |
| DNA polymerase eta | Homo sapiens (human) | IC50 | 0.0620 | 1 | 1 |
| DNA polymerase iota | Homo sapiens (human) | IC50 | 0.0620 | 1 | 1 |
| DNA primase | Mycobacterium tuberculosis CDC1551 | IC50 | 100.0000 | 1 | 1 |
| DNA primase TraC | Escherichia coli | IC50 | 700.0000 | 1 | 1 |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | IC50 | 2.3772 | 5 | 13 |
| DNA topoisomerase 1 | Homo sapiens (human) | IC50 | 164.2000 | 3 | 5 |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | IC50 | 437.5000 | 2 | 4 |
| DNA-(apurinic or apyrimidinic site) endonuclease | Homo sapiens (human) | IC50 | 0.3200 | 2 | 2 |
| DNA-3-methyladenine glycosylase | Homo sapiens (human) | IC50 | 2.6000 | 1 | 1 |
| DNA-dependent protein kinase catalytic subunit | Homo sapiens (human) | IC50 | 1,500.0000 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | IC50 | 3.3890 | 15 | 15 |
| Dual specificity mitogen-activated protein kinase kinase 2 | Homo sapiens (human) | IC50 | 2.7334 | 10 | 10 |
| dual specificity protein phosphatase 3 | Homo sapiens (human) | IC50 | 1.1050 | 2 | 2 |
| dual specificity protein phosphatase 6 | Rattus norvegicus (Norway rat) | IC50 | 39.5000 | 1 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | IC50 | 9.1103 | 6 | 6 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Rattus norvegicus (Norway rat) | IC50 | 0.3300 | 1 | 1 |
| E-selectin | Homo sapiens (human) | IC50 | 500.0000 | 1 | 1 |
| E3 ubiquitin-protein ligase TRIM33 | Homo sapiens (human) | IC50 | 0.3256 | 1 | 1 |
| Ectonucleoside triphosphate diphosphohydrolase 1 | Mus musculus (house mouse) | IC50 | 0.5000 | 1 | 1 |
| ELAV-like protein 1 | Homo sapiens (human) | IC50 | 1.4000 | 1 | 1 |
| ELAV-like protein 3 | Homo sapiens (human) | IC50 | 1.1500 | 1 | 4 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | Escherichia coli K-12 | IC50 | 34.0000 | 2 | 5 |
| Enoyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 2.9864 | 3 | 11 |
| Enoyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | Ki | 1.3425 | 3 | 12 |
| Ephrin type-B receptor 4 | Homo sapiens (human) | IC50 | 1.8300 | 1 | 1 |
| Epidermal growth factor receptor | Homo sapiens (human) | IC50 | 15.1645 | 17 | 17 |
| Epoxide hydrolase 1 | Homo sapiens (human) | IC50 | 7.0000 | 1 | 1 |
| Equilibrative nucleoside transporter 1 | Homo sapiens (human) | Ki | 1,000.0000 | 1 | 1 |
| Estrogen receptor | Homo sapiens (human) | IC50 | 168.3078 | 6 | 6 |
| Estrogen receptor | Homo sapiens (human) | Ki | 0.9998 | 3 | 4 |
| Estrogen receptor 1 | Homo sapiens (human) | IC50 | 23.4338 | 1 | 2 |
| Estrogen receptor beta | Homo sapiens (human) | IC50 | 166.9812 | 5 | 6 |
| estrogen receptor beta isoform 1 | Homo sapiens (human) | IC50 | 2.9272 | 1 | 2 |
| eukaryotic translation initiation factor 4 gamma 1 isoform 4 | Homo sapiens (human) | IC50 | 24.4107 | 1 | 2 |
| eukaryotic translation initiation factor 4E isoform 1 | Mus musculus (house mouse) | IC50 | 24.4107 | 1 | 2 |
| Farnesyl pyrophosphate synthase | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| Fatty acid synthase | Gallus gallus (chicken) | IC50 | 44.1480 | 4 | 5 |
| Fatty acid synthase | Homo sapiens (human) | IC50 | 52.5033 | 2 | 3 |
| Fatty acid-binding protein 5 | Homo sapiens (human) | Ki | 0.2480 | 1 | 1 |
| Fatty acid-binding protein, adipocyte | Homo sapiens (human) | IC50 | 26.1000 | 1 | 1 |
| Fatty acid-binding protein, adipocyte | Homo sapiens (human) | Ki | 0.8425 | 2 | 2 |
| Fatty acid-binding protein, liver | Rattus norvegicus (Norway rat) | Ki | 1.5400 | 2 | 2 |
| Fatty-acid amide hydrolase 1 | Homo sapiens (human) | IC50 | 11.2000 | 3 | 3 |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | IC50 | 4.1540 | 4 | 5 |
| Fatty-acid amide hydrolase 1 | Homo sapiens (human) | Ki | 6.0000 | 1 | 1 |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | Ki | 0.0269 | 1 | 1 |
| Focal adhesion kinase 1 | Homo sapiens (human) | IC50 | 2.1550 | 2 | 2 |
| Forkhead box protein M1 | Homo sapiens (human) | IC50 | 122.4000 | 1 | 1 |
| Forkhead box protein M1 | Homo sapiens (human) | Ki | 0.0520 | 1 | 1 |
| Fructose-1,6-bisphosphatase 1 | Homo sapiens (human) | IC50 | 29.0000 | 1 | 1 |
| G protein-coupled receptor kinase 6 | Homo sapiens (human) | IC50 | 8.7000 | 1 | 1 |
| G-protein coupled receptor 35 | Homo sapiens (human) | IC50 | 6.8617 | 3 | 7 |
| G1/S-specific cyclin-D1 | Homo sapiens (human) | IC50 | 31.0450 | 2 | 2 |
| G2/mitotic-specific cyclin-B | Marthasterias glacialis (spiny starfish) | IC50 | 12.5942 | 1 | 12 |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | IC50 | 18.0850 | 4 | 8 |
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | IC50 | 20.9475 | 2 | 4 |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | IC50 | 20.9475 | 2 | 4 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Ki | 0.3088 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Homo sapiens (human) | Ki | 21.8170 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Ki | 0.3088 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Homo sapiens (human) | Ki | 21.8170 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Ki | 0.3088 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Homo sapiens (human) | Ki | 21.8170 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Ki | 0.3088 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Homo sapiens (human) | Ki | 21.8170 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Ki | 0.3088 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Homo sapiens (human) | Ki | 21.8170 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Ki | 0.3088 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Homo sapiens (human) | Ki | 21.8170 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Ki | 0.3088 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Homo sapiens (human) | Ki | 21.8170 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Ki | 0.3088 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Homo sapiens (human) | Ki | 21.8170 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Ki | 0.3088 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Homo sapiens (human) | Ki | 21.8170 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Ki | 0.3088 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit delta | Homo sapiens (human) | Ki | 21.8170 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Ki | 0.3088 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit epsilon | Homo sapiens (human) | Ki | 21.8170 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Ki | 0.3088 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Homo sapiens (human) | Ki | 21.8170 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Ki | 0.3088 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Homo sapiens (human) | Ki | 21.8170 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Ki | 0.3088 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Homo sapiens (human) | Ki | 21.8170 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Ki | 0.3088 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit pi | Homo sapiens (human) | Ki | 21.8170 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Ki | 0.3088 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit theta | Homo sapiens (human) | Ki | 21.8170 | 1 | 4 |
| Gamma-butyrobetaine dioxygenase | Homo sapiens (human) | IC50 | 0.7420 | 5 | 5 |
| Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | Ki | 0.3020 | 1 | 1 |
| Genome polyprotein | Zika virus | IC50 | 53.5750 | 2 | 4 |
| Genome polyprotein | Zika virus | Ki | 0.8000 | 1 | 1 |
| Glucocorticoid receptor | Homo sapiens (human) | IC50 | 4.7598 | 4 | 4 |
| Glucocorticoid receptor | Homo sapiens (human) | Ki | 0.0124 | 6 | 6 |
| Glucose-6-phosphate 1-dehydrogenase | Homo sapiens (human) | IC50 | 74.5300 | 1 | 1 |
| Glucose-6-phosphate 1-dehydrogenase | Saccharomyces cerevisiae S288C | IC50 | 666.7500 | 1 | 3 |
| glucose-6-phosphate 1-dehydrogenase isoform b | Homo sapiens (human) | IC50 | 57.7333 | 1 | 3 |
| glucose-6-phosphate dehydrogenase | Leuconostoc mesenteroides | IC50 | 25.0000 | 1 | 1 |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | IC50 | 44.9860 | 3 | 10 |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | IC50 | 99.0000 | 4 | 4 |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | IC50 | 125.5000 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | IC50 | 138.5000 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | IC50 | 166.0000 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | IC50 | 232.0000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | IC50 | 232.0000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | IC50 | 232.0000 | 1 | 1 |
| Glutathione reductase | Plasmodium falciparum 3D7 | IC50 | 6.4000 | 1 | 1 |
| Glutathione reductase | Saccharomyces cerevisiae S288C | IC50 | 48.8000 | 1 | 1 |
| Glutathione reductase, mitochondrial | Homo sapiens (human) | IC50 | 68.3000 | 4 | 4 |
| Glutathione S-transferase | Plasmodium falciparum 3D7 | IC50 | 74.4000 | 1 | 1 |
| Glutathione S-transferase Mu 1 | Mus musculus (house mouse) | IC50 | 100.0000 | 1 | 1 |
| Glutathione S-transferase omega-1 | Homo sapiens (human) | IC50 | 62.0000 | 1 | 1 |
| Glutathione S-transferase P | Homo sapiens (human) | IC50 | 42.5333 | 3 | 3 |
| glutathione-S-transferase | Schistosoma japonicum | IC50 | 58.0400 | 1 | 1 |
| Glyceraldehyde-3-phosphate dehydrogenase, glycosomal | Trypanosoma cruzi | IC50 | 145.5000 | 1 | 2 |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | IC50 | 0.0190 | 1 | 1 |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Ki | 0.0086 | 1 | 1 |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | IC50 | 0.0190 | 1 | 1 |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Ki | 0.0086 | 1 | 1 |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | IC50 | 0.0190 | 1 | 1 |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Ki | 0.0086 | 1 | 1 |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | IC50 | 0.0190 | 1 | 1 |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | Ki | 0.0086 | 1 | 1 |
| Glycogen phosphorylase, liver form | Homo sapiens (human) | IC50 | 4.8000 | 1 | 1 |
| Glycogen phosphorylase, liver form | Rattus norvegicus (Norway rat) | IC50 | 99.0000 | 1 | 1 |
| Glycogen phosphorylase, muscle form | Oryctolagus cuniculus (rabbit) | IC50 | 52.9521 | 3 | 6 |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | IC50 | 1.6720 | 4 | 6 |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | Ki | 0.0308 | 1 | 1 |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | IC50 | 1.3064 | 12 | 14 |
| Glycogen synthase kinase-3 beta | Rattus norvegicus (Norway rat) | IC50 | 12.5942 | 1 | 12 |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | Ki | 0.0240 | 1 | 1 |
| heat shock 70kDa protein 1A | Homo sapiens (human) | IC50 | 66.9200 | 3 | 3 |
| heat shock cognate 71 kDa protein isoform 1 | Homo sapiens (human) | IC50 | 99.6000 | 2 | 2 |
| heat shock cognate 71 kDa protein isoform 2 | Homo sapiens (human) | IC50 | 99.6000 | 2 | 2 |
| Heat shock factor protein 1 | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| heat shock protein HSP 90-alpha isoform 2 | Homo sapiens (human) | IC50 | 16.3116 | 2 | 2 |
| Heat shock protein HSP 90-beta | Homo sapiens (human) | IC50 | 84.2500 | 2 | 2 |
| Heme oxygenase 1 | Rattus norvegicus (Norway rat) | IC50 | 18.0000 | 1 | 1 |
| Heme oxygenase 2 | Rattus norvegicus (Norway rat) | IC50 | 18.0000 | 1 | 1 |
| Hepatocyte growth factor receptor | Homo sapiens (human) | IC50 | 7.7900 | 4 | 4 |
| Hepatocyte growth factor receptor | Homo sapiens (human) | Ki | 3.3000 | 1 | 1 |
| hexokinase | Trypanosoma brucei brucei TREU927 | IC50 | 11.6394 | 2 | 2 |
| Histamine H2 receptor | Homo sapiens (human) | IC50 | 27.9200 | 1 | 1 |
| Histamine H2 receptor | Homo sapiens (human) | Ki | 27.4530 | 1 | 1 |
| Histamine H3 receptor | Rattus norvegicus (Norway rat) | Ki | 0.2940 | 1 | 1 |
| Histone acetyltransferase KAT2B | Homo sapiens (human) | IC50 | 60.0000 | 2 | 2 |
| Histone acetyltransferase KAT5 | Homo sapiens (human) | IC50 | 70.0000 | 2 | 2 |
| Histone acetyltransferase p300 | Homo sapiens (human) | IC50 | 30.0000 | 2 | 2 |
| Histone deacetylase 1 | Homo sapiens (human) | IC50 | 3,160.0000 | 1 | 1 |
| Histone deacetylase 11 | Homo sapiens (human) | IC50 | 3,160.0000 | 1 | 1 |
| Histone deacetylase 2 | Homo sapiens (human) | IC50 | 3,160.0000 | 1 | 1 |
| Histone deacetylase 3 | Homo sapiens (human) | IC50 | 3,160.0000 | 1 | 1 |
| Histone deacetylase 4 | Homo sapiens (human) | IC50 | 3,160.0000 | 1 | 1 |
| Histone deacetylase 5 | Homo sapiens (human) | IC50 | 1,581.7000 | 2 | 2 |
| Histone deacetylase 6 | Homo sapiens (human) | IC50 | 794.9000 | 4 | 4 |
| Histone deacetylase 7 | Homo sapiens (human) | IC50 | 3,160.0000 | 1 | 1 |
| Histone deacetylase 8 | Homo sapiens (human) | IC50 | 3,160.0000 | 1 | 1 |
| Histone deacetylase 9 | Homo sapiens (human) | IC50 | 1,581.8500 | 2 | 2 |
| Histone-lysine N-methyltransferase EHMT1 | Homo sapiens (human) | IC50 | 0.7300 | 1 | 1 |
| Histone-lysine N-methyltransferase EHMT2 | Homo sapiens (human) | IC50 | 0.4000 | 1 | 1 |
| Histone-lysine N-methyltransferase SETD7 | Homo sapiens (human) | IC50 | 6.0200 | 1 | 1 |
| Hyaluronidase-1 | Homo sapiens (human) | IC50 | 2,000.0000 | 1 | 2 |
| Hydroxycarboxylic acid receptor 2 | Homo sapiens (human) | Ki | 0.1800 | 1 | 1 |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | IC50 | 0.2500 | 1 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | Homo sapiens (human) | IC50 | 10.2000 | 1 | 1 |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | IC50 | 8.4100 | 1 | 1 |
| Indoleamine 2,3-dioxygenase 1 | Mus musculus (house mouse) | IC50 | 140.7333 | 1 | 3 |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | Ki | 0.0940 | 3 | 3 |
| Indoleamine 2,3-dioxygenase 2 | Mus musculus (house mouse) | IC50 | 17.3000 | 1 | 3 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens (human) | IC50 | 12.0175 | 2 | 4 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens (human) | Ki | 2.7300 | 1 | 3 |
| Inhibin alpha chain | Homo sapiens (human) | IC50 | 5.2000 | 1 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta | Homo sapiens (human) | IC50 | 5.2300 | 2 | 3 |
| Inositol hexakisphosphate kinase 2 | Homo sapiens (human) | IC50 | 1.0250 | 1 | 4 |
| Inositol polyphosphate multikinase | Homo sapiens (human) | IC50 | 6.1500 | 1 | 4 |
| Insulin receptor | Homo sapiens (human) | IC50 | 0.3400 | 1 | 1 |
| Insulin receptor | Homo sapiens (human) | Ki | 2.6000 | 1 | 1 |
| Insulin-degrading enzyme | Homo sapiens (human) | IC50 | 50.0140 | 3 | 4 |
| Insulin-like growth factor 1 receptor | Homo sapiens (human) | IC50 | 0.4833 | 3 | 3 |
| Integrase | Human immunodeficiency virus 1 | IC50 | 17.3128 | 15 | 40 |
| integrase, partial | Human immunodeficiency virus 1 | IC50 | 8.0053 | 2 | 8 |
| Interstitial collagenase | Homo sapiens (human) | IC50 | 3.0867 | 1 | 3 |
| intestinal alkaline phosphatase precursor | Mus musculus (house mouse) | IC50 | 5.1733 | 1 | 3 |
| Islet amyloid polypeptide | Homo sapiens (human) | IC50 | 7.8000 | 1 | 1 |
| Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens (human) | Ki | 2.8500 | 1 | 1 |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | IC50 | 187.7500 | 2 | 4 |
| Kelch-like ECH-associated protein 1 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| L-lactate dehydrogenase A chain | Homo sapiens (human) | IC50 | 500.0000 | 1 | 1 |
| L-ornithine N(5)-monooxygenase | Aspergillus fumigatus Af293 | IC50 | 11.0000 | 2 | 2 |
| L-selectin | Homo sapiens (human) | IC50 | 27.6000 | 1 | 1 |
| Lactoperoxidase | Bos taurus (cattle) | IC50 | 6.1000 | 1 | 1 |
| Lactoylglutathione lyase | Homo sapiens (human) | IC50 | 3.7400 | 3 | 5 |
| Lactoylglutathione lyase | Homo sapiens (human) | Ki | 35.4235 | 1 | 4 |
| large T antigen | Betapolyomavirus macacae | IC50 | 20.7570 | 1 | 10 |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | IC50 | 8.0053 | 2 | 8 |
| Lethal factor | Bacillus anthracis | IC50 | 0.0970 | 1 | 1 |
| Leukotriene A-4 hydrolase | Homo sapiens (human) | IC50 | 289.0000 | 2 | 2 |
| Leukotriene B4 receptor 1 | Homo sapiens (human) | IC50 | 0.0850 | 1 | 1 |
| likely tRNA 2'-phosphotransferase | Candida albicans SC5314 | IC50 | 0.2913 | 2 | 2 |
| Linoleate 9S-lipoxygenase-4 | Glycine max (soybean) | IC50 | 22.0000 | 1 | 1 |
| Lipoxygenase | Glycine max (soybean) | IC50 | 23.3460 | 5 | 5 |
| Lipoxygenase | Solanum tuberosum (potato) | IC50 | 10.0000 | 1 | 1 |
| Low molecular weight phosphotyrosine protein phosphatase | Bos taurus (cattle) | IC50 | 10.0000 | 1 | 1 |
| Luciferin 4-monooxygenase | Photinus pyralis (common eastern firefly) | IC50 | 0.0589 | 1 | 1 |
| Lysine-specific demethylase 4E | Homo sapiens (human) | IC50 | 3.0000 | 1 | 2 |
| Lysine-specific demethylase 4E | Homo sapiens (human) | Ki | 4.3300 | 1 | 1 |
| Lysine-specific histone demethylase 1A | Homo sapiens (human) | IC50 | 12.0518 | 10 | 17 |
| Lysine-specific histone demethylase 1A | Homo sapiens (human) | Ki | 1.0000 | 1 | 1 |
| Lysosomal alpha-glucosidase | Homo sapiens (human) | IC50 | 171.1667 | 3 | 3 |
| Lysosomal alpha-glucosidase | Rattus norvegicus (Norway rat) | IC50 | 400.0000 | 1 | 2 |
| Lysosomal alpha-glucosidase | Homo sapiens (human) | Ki | 7.3000 | 1 | 1 |
| M1-family alanyl aminopeptidase | Plasmodium falciparum 3D7 | IC50 | 48.2000 | 1 | 1 |
| M17 leucyl aminopeptidase | Plasmodium falciparum 3D7 | IC50 | 86.6900 | 2 | 2 |
| M18 aspartyl aminopeptidase | Plasmodium falciparum 3D7 | IC50 | 15.9360 | 2 | 3 |
| Macrophage metalloelastase | Homo sapiens (human) | IC50 | 10.2300 | 1 | 1 |
| Macrophage migration inhibitory factor | Homo sapiens (human) | IC50 | 65.2283 | 5 | 6 |
| Macrophage migration inhibitory factor | Homo sapiens (human) | Ki | 66.0180 | 4 | 5 |
| Malate dehydrogenase | Thermus thermophilus | IC50 | 53.0000 | 1 | 2 |
| Maltase-glucoamylase, intestinal | Homo sapiens (human) | IC50 | 8.1000 | 3 | 3 |
| Maltase-glucoamylase, intestinal | Homo sapiens (human) | Ki | 7.3000 | 1 | 1 |
| MAP kinase-activated protein kinase 5 | Homo sapiens (human) | IC50 | 33.6667 | 3 | 3 |
| MAP kinase-interacting serine/threonine-protein kinase 1 | Homo sapiens (human) | IC50 | 1.2050 | 1 | 1 |
| MAP kinase-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | IC50 | 0.2520 | 1 | 1 |
| MAP/microtubule affinity-regulating kinase 4 | Homo sapiens (human) | IC50 | 1.7700 | 1 | 1 |
| Matrilysin | Homo sapiens (human) | IC50 | 35.8288 | 2 | 16 |
| Matrix metalloproteinase-14 | Homo sapiens (human) | IC50 | 6.8000 | 1 | 1 |
| Matrix metalloproteinase-9 | Homo sapiens (human) | IC50 | 13.4168 | 5 | 5 |
| Mcl-1 | Homo sapiens (human) | IC50 | 19.1861 | 2 | 3 |
| Melatonin receptor type 1A | Homo sapiens (human) | Ki | 1.9000 | 1 | 1 |
| Methionine aminopeptidase 2 | Homo sapiens (human) | IC50 | 2.4300 | 1 | 1 |
| microphthalmia-associated transcription factor isoform 9 | Homo sapiens (human) | IC50 | 6.3810 | 3 | 3 |
| Microtubule-associated protein tau | Homo sapiens (human) | IC50 | 30.4625 | 5 | 8 |
| Microtubule-associated protein tau | Rattus norvegicus (Norway rat) | IC50 | 0.2000 | 1 | 1 |
| Mineralocorticoid receptor | Homo sapiens (human) | IC50 | 1.1970 | 3 | 3 |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | IC50 | 0.8333 | 1 | 3 |
| Mitogen-activated protein kinase 10 | Homo sapiens (human) | IC50 | 30.1065 | 1 | 34 |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | IC50 | 30.0231 | 3 | 36 |
| Mitogen-activated protein kinase 8 | Mus musculus (house mouse) | IC50 | 4.6000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 8 | Homo sapiens (human) | IC50 | 2.3700 | 1 | 1 |
| MO15-related protein kinase Pfmrk | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 157.0000 | 1 | 1 |
| Monocarboxylate transporter 1 | Rattus norvegicus (Norway rat) | IC50 | 14.0000 | 1 | 1 |
| Monocarboxylate transporter 2 | Rattus norvegicus (Norway rat) | IC50 | 5.0000 | 1 | 1 |
| mothers against decapentaplegic homolog 3 isoform 1 | Homo sapiens (human) | IC50 | 25.0710 | 2 | 2 |
| MPI protein | Homo sapiens (human) | IC50 | 25.1452 | 3 | 4 |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | IC50 | 254.4200 | 4 | 4 |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | Ki | 0.0350 | 1 | 1 |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 0.0560 | 1 | 1 |
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | IC50 | 8.6667 | 1 | 3 |
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | Ki | 6.5500 | 2 | 4 |
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | IC50 | 90.9000 | 1 | 7 |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | IC50 | 0.5700 | 1 | 4 |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | IC50 | 0.5700 | 1 | 3 |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | IC50 | 0.5700 | 1 | 3 |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | IC50 | 0.5700 | 1 | 3 |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | IC50 | 0.5700 | 1 | 3 |
| Myc proto-oncogene protein | Homo sapiens (human) | IC50 | 60.0000 | 1 | 1 |
| Myeloperoxidase | Homo sapiens (human) | IC50 | 1.9200 | 5 | 5 |
| Myosin light chain kinase, smooth muscle | Homo sapiens (human) | Ki | 1.7000 | 1 | 1 |
| N-acylethanolamine-hydrolyzing acid amidase | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| N1L | Vaccinia virus | IC50 | 21.9000 | 2 | 2 |
| NACHT, LRR and PYD domains-containing protein 3 | Mus musculus (house mouse) | IC50 | 10.0000 | 1 | 1 |
| NAD kinase | Homo sapiens (human) | IC50 | 50.4800 | 2 | 2 |
| NAD kinase | Homo sapiens (human) | Ki | 3.2800 | 1 | 1 |
| NAD-dependent histone deacetylase SIR2 | Saccharomyces cerevisiae S288C | IC50 | 50.0000 | 1 | 1 |
| NAD-dependent protein deacetylase | Schistosoma mansoni | IC50 | 148.3333 | 3 | 3 |
| NAD-dependent protein deacetylase HST2 | Saccharomyces cerevisiae S288C | IC50 | 91.0000 | 1 | 1 |
| NAD-dependent protein deacetylase sirtuin-1 | Homo sapiens (human) | IC50 | 130.9500 | 12 | 12 |
| NAD-dependent protein deacetylase sirtuin-2 | Homo sapiens (human) | IC50 | 27.3667 | 15 | 15 |
| NAD-dependent protein deacetylase sirtuin-3, mitochondrial | Homo sapiens (human) | IC50 | 78.4571 | 7 | 7 |
| NAD-dependent protein deacetylase sirtuin-6 | Homo sapiens (human) | IC50 | 173.3500 | 4 | 4 |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | Homo sapiens (human) | IC50 | 44.0500 | 4 | 4 |
| NAD(+) hydrolase SARM1 | Homo sapiens (human) | IC50 | 43.8000 | 1 | 1 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 subunit C2 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-cytochrome b5 reductase 3 | Homo sapiens (human) | IC50 | 279.4000 | 1 | 1 |
| NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-ubiquinone oxidoreductase chain 1 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-ubiquinone oxidoreductase chain 2 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-ubiquinone oxidoreductase chain 3 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-ubiquinone oxidoreductase chain 4 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-ubiquinone oxidoreductase chain 4L | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-ubiquinone oxidoreductase chain 5 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-ubiquinone oxidoreductase chain 6 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADPH oxidase 4 | Homo sapiens (human) | IC50 | 0.6800 | 1 | 1 |
| Neuraminidase | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) | IC50 | 7.7500 | 1 | 1 |
| Neuraminidase | Influenza A virus (A/USSR/90/1977(H1N1)) | IC50 | 145.8700 | 4 | 10 |
| Neuraminidase | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) | Ki | 14.3000 | 1 | 1 |
| Neuraminidase | Influenza A virus (A/Wilson-Smith/1933(H1N1)) | IC50 | 52.2983 | 7 | 23 |
| Neuraminidase | Influenza A virus (A/Wilson-Smith/1933(H1N1)) | Ki | 18.8000 | 1 | 2 |
| Neuronal acetylcholine receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | IC50 | 0.7300 | 2 | 3 |
| Neuronal acetylcholine receptor subunit beta-2 | Rattus norvegicus (Norway rat) | IC50 | 0.7300 | 2 | 3 |
| neutrophil cytosol factor 1 | Homo sapiens (human) | IC50 | 0.3900 | 1 | 2 |
| Neutrophil cytosol factor 1 | Homo sapiens (human) | Ki | 125.0000 | 3 | 3 |
| Neutrophil elastase | Homo sapiens (human) | IC50 | 12.7020 | 4 | 4 |
| Neutrophil elastase | Homo sapiens (human) | Ki | 11.9000 | 1 | 1 |
| Nitric oxide synthase, inducible | Mus musculus (house mouse) | IC50 | 21.3667 | 6 | 6 |
| Non-structural protein 1 | Dengue virus | IC50 | 1.7000 | 1 | 1 |
| nonstructural protein 1 | Influenza A virus (A/California/07/2009(H1N1)) | IC50 | 19.2240 | 1 | 1 |
| NUAK family SNF1-like kinase 1 | Homo sapiens (human) | IC50 | 2.8000 | 2 | 2 |
| Nuclear factor erythroid 2-related factor 2 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) | IC50 | 20.2500 | 2 | 2 |
| Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | IC50 | 27.6250 | 4 | 4 |
| Nuclear receptor ROR-alpha | Homo sapiens (human) | IC50 | 0.1995 | 1 | 1 |
| Nuclear receptor ROR-beta | Homo sapiens (human) | IC50 | 12.6224 | 2 | 2 |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | IC50 | 0.1995 | 1 | 1 |
| nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | IC50 | 34.2344 | 1 | 2 |
| Nuclear receptor subfamily 1 group I member 2 | Homo sapiens (human) | IC50 | 12.0000 | 1 | 1 |
| Nucleophosmin | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
| Oligo-1,6-glucosidase IMA1 | Saccharomyces cerevisiae S288C | IC50 | 530.0000 | 1 | 1 |
| Ornithine decarboxylase | Homo sapiens (human) | IC50 | 19.0000 | 1 | 1 |
| Ornithine decarboxylase | Rattus norvegicus (Norway rat) | Ki | 3,500.0000 | 1 | 1 |
| P-selectin | Homo sapiens (human) | IC50 | 19.1000 | 1 | 1 |
| P2Y purinoceptor 12 | Rattus norvegicus (Norway rat) | IC50 | 25.5000 | 1 | 1 |
| P2Y purinoceptor 12 | Homo sapiens (human) | Ki | 36.4000 | 1 | 1 |
| Palmitoleoyl-protein carboxylesterase NOTUM | Homo sapiens (human) | IC50 | 93.6000 | 1 | 1 |
| Pancreatic alpha-amylase | Sus scrofa (pig) | IC50 | 73.9000 | 1 | 1 |
| Pancreatic triacylglycerol lipase | Homo sapiens (human) | IC50 | 36.0000 | 1 | 1 |
| Pancreatic triacylglycerol lipase | Sus scrofa (pig) | IC50 | 302.0571 | 6 | 7 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | IC50 | 10.4100 | 2 | 2 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | Ki | 0.8200 | 1 | 1 |
| perilipin-1 | Homo sapiens (human) | IC50 | 3.4100 | 1 | 1 |
| perilipin-5 | Homo sapiens (human) | IC50 | 1.1010 | 1 | 1 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | IC50 | 1.0300 | 6 | 6 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | Ki | 0.3168 | 5 | 5 |
| Phosphatidylinositol 3-kinase regulatory subunit alpha | Homo sapiens (human) | IC50 | 3.8000 | 1 | 1 |
| Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN | Homo sapiens (human) | IC50 | 13.3000 | 1 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Homo sapiens (human) | IC50 | 6.4000 | 1 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Homo sapiens (human) | IC50 | 6.0275 | 2 | 4 |
| Phosphodiesterase | Rattus norvegicus (Norway rat) | IC50 | 275.0000 | 1 | 1 |
| phosphoethanolamine/phosphocholine phosphatase isoform 1 | Homo sapiens (human) | IC50 | 0.1110 | 1 | 1 |
| Phosphoglycerate mutase 1 | Homo sapiens (human) | IC50 | 2.7267 | 3 | 3 |
| Phospholipase A2 | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
| phosphomannomutase 2 | Homo sapiens (human) | IC50 | 0.6720 | 1 | 1 |
| Plasminogen activator inhibitor 1 | Homo sapiens (human) | IC50 | 3.3455 | 1 | 2 |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | IC50 | 1.3000 | 1 | 1 |
| Poly [ADP-ribose] polymerase 1 | Homo sapiens (human) | IC50 | 187.0070 | 6 | 7 |
| Poly [ADP-ribose] polymerase 2 | Mus musculus (house mouse) | IC50 | 129.5245 | 1 | 2 |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | IC50 | 3,160.0000 | 1 | 1 |
| Polymerase acidic protein | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) | IC50 | 5.8600 | 1 | 1 |
| Polypeptide N-acetylgalactosaminyltransferase 2 | Homo sapiens (human) | IC50 | 1.6033 | 2 | 3 |
| Polyphenol oxidase 2 | Agaricus bisporus | IC50 | 840.6661 | 21 | 31 |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | IC50 | 10.0868 | 27 | 32 |
| Polyunsaturated fatty acid 5-lipoxygenase | Mus musculus (house mouse) | IC50 | 0.4000 | 1 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | IC50 | 2.0645 | 11 | 19 |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | Ki | 0.1170 | 1 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX12 | Homo sapiens (human) | IC50 | 13.3477 | 7 | 13 |
| Polyunsaturated fatty acid lipoxygenase ALOX12 | Homo sapiens (human) | Ki | 1.6000 | 1 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Homo sapiens (human) | IC50 | 14.2742 | 13 | 19 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | IC50 | 8.8796 | 4 | 5 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Homo sapiens (human) | Ki | 0.6000 | 1 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) | IC50 | 52.9318 | 4 | 11 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | Rattus norvegicus (Norway rat) | IC50 | 0.2600 | 1 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | IC50 | 66.0693 | 1 | 1 |
| Probable maltase-glucoamylase 2 | Homo sapiens (human) | IC50 | 6.7500 | 2 | 2 |
| Probable maltase-glucoamylase 2 | Homo sapiens (human) | Ki | 7.3000 | 1 | 1 |
| Procathepsin L | Homo sapiens (human) | IC50 | 0.6700 | 1 | 1 |
| Progesterone receptor | Homo sapiens (human) | IC50 | 5.0065 | 5 | 5 |
| Progesterone receptor | Homo sapiens (human) | Ki | 0.0005 | 8 | 8 |
| Prolyl 4-hydroxylase subunit alpha-1 | Gallus gallus (chicken) | Ki | 2,816.4000 | 1 | 5 |
| Prolyl endopeptidase | Homo sapiens (human) | IC50 | 80.0429 | 4 | 7 |
| Prolyl endopeptidase | Rattus norvegicus (Norway rat) | Ki | 0.0200 | 1 | 1 |
| Prostaglandin D2 receptor 2 | Homo sapiens (human) | IC50 | 0.0607 | 1 | 1 |
| Prostaglandin E synthase | Homo sapiens (human) | IC50 | 2.6333 | 2 | 3 |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | IC50 | 10,068.3154 | 8 | 18 |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | IC50 | 33.1000 | 8 | 9 |
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | IC50 | 1,293.8100 | 7 | 10 |
| Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | IC50 | 46.0000 | 2 | 5 |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | IC50 | 5,032.5451 | 18 | 24 |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | IC50 | 1,826.5817 | 4 | 6 |
| Prostaglandin G/H synthase 2 | Bos taurus (cattle) | IC50 | 14.0000 | 1 | 1 |
| Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | IC50 | 46.0000 | 2 | 5 |
| Protease | Human immunodeficiency virus 1 | IC50 | 31.4700 | 2 | 2 |
| Proteasome subunit beta type-5 | Homo sapiens (human) | IC50 | 759.7805 | 5 | 11 |
| Protein E6 | Human papillomavirus 16 | IC50 | 8.2833 | 1 | 3 |
| Protein kinase C alpha type | Rattus norvegicus (Norway rat) | IC50 | 20.0000 | 1 | 2 |
| Protein kinase C beta type | Rattus norvegicus (Norway rat) | IC50 | 20.0000 | 1 | 2 |
| Protein kinase C delta type | Rattus norvegicus (Norway rat) | IC50 | 20.0000 | 1 | 2 |
| Protein kinase C epsilon type | Rattus norvegicus (Norway rat) | IC50 | 20.0000 | 1 | 2 |
| Protein kinase C eta type | Rattus norvegicus (Norway rat) | IC50 | 20.0000 | 1 | 2 |
| Protein kinase C gamma type | Rattus norvegicus (Norway rat) | IC50 | 20.0000 | 1 | 2 |
| Protein kinase C theta type | Rattus norvegicus (Norway rat) | IC50 | 20.0000 | 1 | 2 |
| Protein kinase C zeta type | Rattus norvegicus (Norway rat) | IC50 | 20.0000 | 1 | 2 |
| Protein mono-ADP-ribosyltransferase PARP15 | Homo sapiens (human) | IC50 | 15.0000 | 1 | 1 |
| Prothrombin | Homo sapiens (human) | IC50 | 369.6056 | 6 | 9 |
| Prothrombin | Homo sapiens (human) | Ki | 0.2672 | 1 | 1 |
| Prothrombin | Bos taurus (cattle) | IC50 | 28.7500 | 1 | 4 |
| Proto-oncogene c-Fos | Homo sapiens (human) | IC50 | 0.0079 | 1 | 1 |
| Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | IC50 | 59.0500 | 2 | 2 |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | IC50 | 20.9314 | 7 | 7 |
| Proton-coupled amino acid transporter 1 | Homo sapiens (human) | Ki | 7,800.0000 | 1 | 1 |
| Pyruvate kinase PKM | Homo sapiens (human) | IC50 | 35.4075 | 4 | 4 |
| rac GTPase-activating protein 1 isoform a | Homo sapiens (human) | IC50 | 90.9867 | 1 | 3 |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | IC50 | 22.9100 | 3 | 3 |
| RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | IC50 | 0.2900 | 1 | 1 |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | IC50 | 9.0717 | 5 | 5 |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | IC50 | 8.1489 | 5 | 9 |
| Receptor-type tyrosine-protein phosphatase epsilon | Homo sapiens (human) | IC50 | 500.0000 | 1 | 1 |
| Receptor-type tyrosine-protein phosphatase eta | Homo sapiens (human) | IC50 | 111.5000 | 1 | 1 |
| Receptor-type tyrosine-protein phosphatase F | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
| Receptor-type tyrosine-protein phosphatase S | Homo sapiens (human) | IC50 | 7.3000 | 1 | 2 |
| Regulator of G-protein signaling 17 | Homo sapiens (human) | IC50 | 27.9338 | 5 | 5 |
| Renin | Homo sapiens (human) | IC50 | 0.9800 | 1 | 1 |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | IC50 | 0.6700 | 1 | 1 |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | IC50 | 9.0670 | 2 | 10 |
| Replicase polyprotein 1ab | Human coronavirus 229E | IC50 | 0.6700 | 1 | 1 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | IC50 | 3.4384 | 21 | 42 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | IC50 | 22.9194 | 10 | 16 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | Ki | 5.8000 | 1 | 2 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | Ki | 8.6600 | 3 | 5 |
| Retinoic acid receptor alpha | Homo sapiens (human) | IC50 | 2.2542 | 4 | 4 |
| Retinoic acid receptor alpha | Mus musculus (house mouse) | IC50 | 0.0057 | 3 | 3 |
| Retinoic acid receptor alpha | Homo sapiens (human) | Ki | 0.0688 | 3 | 3 |
| Retinoic acid receptor beta | Homo sapiens (human) | IC50 | 0.7537 | 4 | 4 |
| Retinoic acid receptor beta | Mus musculus (house mouse) | IC50 | 0.0050 | 2 | 2 |
| Retinoic acid receptor beta | Homo sapiens (human) | Ki | 0.0095 | 3 | 3 |
| Retinoic acid receptor gamma | Mus musculus (house mouse) | IC50 | 0.0040 | 2 | 2 |
| Retinoic acid receptor gamma | Homo sapiens (human) | IC50 | 0.0064 | 3 | 3 |
| Retinoic acid receptor gamma | Homo sapiens (human) | Ki | 0.0844 | 4 | 5 |
| Retinoic acid receptor RXR-alpha | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Retinoic acid receptor RXR-alpha | Mus musculus (house mouse) | IC50 | 18.0000 | 3 | 3 |
| Retinoic acid receptor RXR-alpha | Homo sapiens (human) | Ki | 0.7201 | 3 | 4 |
| Retinoic acid receptor RXR-beta | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Retinoic acid receptor RXR-beta | Mus musculus (house mouse) | IC50 | 50.0000 | 1 | 1 |
| Retinoic acid receptor RXR-beta | Homo sapiens (human) | Ki | 0.9339 | 3 | 4 |
| Retinoic acid receptor RXR-gamma | Homo sapiens (human) | IC50 | 0.3500 | 1 | 1 |
| Retinoic acid receptor RXR-gamma | Mus musculus (house mouse) | IC50 | 50.0000 | 1 | 1 |
| Retinoic acid receptor RXR-gamma | Homo sapiens (human) | Ki | 1.6024 | 3 | 4 |
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | IC50 | 66.4325 | 2 | 4 |
| Rhodopsin | Bos taurus (cattle) | IC50 | 180.0000 | 1 | 1 |
| Riboflavin-binding protein | Gallus gallus (chicken) | Ki | 0.3500 | 1 | 1 |
| Ribonuclease HI | Escherichia coli K-12 | IC50 | 20.0000 | 1 | 1 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | IC50 | 2.2690 | 12 | 14 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | Ki | 0.0880 | 1 | 1 |
| RNA polymerase beta subunit (EC 2.7.7.6), partial | Escherichia coli | IC50 | 12.0617 | 1 | 2 |
| RNA-directed RNA polymerase | | IC50 | 20.0000 | 1 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | IC50 | 10.5000 | 2 | 2 |
| Secreted chorismate mutase | Mycobacterium tuberculosis H37Rv | IC50 | 24.8000 | 1 | 1 |
| Seed linoleate 13S-lipoxygenase-1 | Glycine max (soybean) | IC50 | 13.1350 | 8 | 8 |
| Seed linoleate 13S-lipoxygenase-1 | Glycine max (soybean) | Ki | 49.3667 | 3 | 3 |
| Seed linoleate 9S-lipoxygenase | Glycine max (soybean) | IC50 | 400.0000 | 1 | 1 |
| Sepiapterin reductase | Homo sapiens (human) | IC50 | 5.0000 | 1 | 1 |
| Serine-protein kinase ATM | Homo sapiens (human) | IC50 | 0.2000 | 1 | 1 |
| Serine/threonine-protein kinase ATR | Homo sapiens (human) | IC50 | 0.2000 | 1 | 1 |
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | IC50 | 2.7902 | 3 | 4 |
| Serine/threonine-protein kinase N1 | Homo sapiens (human) | IC50 | 5.8000 | 1 | 1 |
| Serine/threonine-protein kinase Nek2 | Homo sapiens (human) | IC50 | 5.7300 | 1 | 1 |
| Serine/threonine-protein kinase Nek6 | Homo sapiens (human) | IC50 | 4.2300 | 1 | 1 |
| Serine/threonine-protein kinase PAK 1 | Homo sapiens (human) | IC50 | 15.0000 | 1 | 1 |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | IC50 | 12.2706 | 11 | 20 |
| Serine/threonine-protein kinase pim-2 | Homo sapiens (human) | IC50 | 25.0000 | 1 | 1 |
| Serine/threonine-protein kinase PLK1 | Homo sapiens (human) | IC50 | 14.3543 | 6 | 7 |
| Serine/threonine-protein kinase PLK2 | Homo sapiens (human) | IC50 | 164.3600 | 2 | 2 |
| Serine/threonine-protein kinase PLK3 | Homo sapiens (human) | IC50 | 45.0000 | 2 | 2 |
| Serine/threonine-protein kinase PLK4 | Homo sapiens (human) | IC50 | 2.9700 | 1 | 1 |
| Serine/threonine-protein kinase/endoribonuclease IRE1 | Homo sapiens (human) | IC50 | 1.3000 | 1 | 1 |
| Short transient receptor potential channel 5 | Homo sapiens (human) | IC50 | 8.2500 | 1 | 2 |
| Sialidase | Clostridium perfringens | IC50 | 13.6125 | 5 | 8 |
| Sialidase | Clostridium perfringens | Ki | 5.8000 | 1 | 1 |
| Sialidase-1 | Homo sapiens (human) | IC50 | 500.0000 | 1 | 1 |
| Sialidase-2 | Homo sapiens (human) | IC50 | 366.0000 | 2 | 5 |
| Sialidase-3 | Homo sapiens (human) | IC50 | 500.0000 | 1 | 1 |
| Sialidase-4 | Homo sapiens (human) | IC50 | 500.0000 | 1 | 1 |
| Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | IC50 | 10.0000 | 1 | 1 |
| Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | IC50 | 40.0000 | 1 | 2 |
| Sodium- and chloride-dependent betaine transporter | Rattus norvegicus (Norway rat) | IC50 | 43.3333 | 1 | 3 |
| Sodium- and chloride-dependent GABA transporter 1 | Rattus norvegicus (Norway rat) | IC50 | 43.3333 | 1 | 3 |
| Sodium- and chloride-dependent GABA transporter 2 | Rattus norvegicus (Norway rat) | IC50 | 43.3333 | 1 | 3 |
| Sodium- and chloride-dependent GABA transporter 3 | Rattus norvegicus (Norway rat) | IC50 | 43.3333 | 1 | 3 |
| Sodium- and chloride-dependent taurine transporter | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | IC50 | 510.0000 | 2 | 2 |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | Ki | 0.0352 | 1 | 1 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | IC50 | 2.2950 | 1 | 3 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | Ki | 2.2763 | 1 | 3 |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | IC50 | 1.0000 | 1 | 1 |
| Sodium/glucose cotransporter 1 | Homo sapiens (human) | IC50 | 15.8405 | 13 | 14 |
| Sodium/glucose cotransporter 1 | Homo sapiens (human) | Ki | 0.1800 | 1 | 1 |
| Sodium/glucose cotransporter 1 | Rattus norvegicus (Norway rat) | IC50 | 0.3500 | 1 | 1 |
| Sodium/glucose cotransporter 2 | Homo sapiens (human) | IC50 | 7.5315 | 13 | 14 |
| Sodium/glucose cotransporter 2 | Rattus norvegicus (Norway rat) | IC50 | 0.0960 | 1 | 1 |
| Sodium/glucose cotransporter 2 | Homo sapiens (human) | Ki | 0.0186 | 1 | 1 |
| Sodium/nucleoside cotransporter 1 | Homo sapiens (human) | IC50 | 250.0000 | 1 | 1 |
| Sodium/nucleoside cotransporter 2 | Homo sapiens (human) | IC50 | 550.0000 | 2 | 2 |
| Solute carrier family 15 member 1 | Rattus norvegicus (Norway rat) | Ki | 8,000.0000 | 1 | 1 |
| Solute carrier family 15 member 2 | Homo sapiens (human) | IC50 | 28.0000 | 1 | 1 |
| Solute carrier family 15 member 2 | Rattus norvegicus (Norway rat) | Ki | 66.0000 | 1 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 2 | Homo sapiens (human) | IC50 | 12.0000 | 2 | 4 |
| Solute carrier family 2, facilitated glucose transporter member 4 | Mus musculus (house mouse) | Ki | 60.0000 | 1 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 4 | Rattus norvegicus (Norway rat) | Ki | 24.7500 | 1 | 2 |
| Solute carrier family 22 member 12 | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
| Solute carrier family 22 member 12 | Rattus norvegicus (Norway rat) | IC50 | 18.0000 | 1 | 1 |
| Solute carrier family 22 member 12 | Homo sapiens (human) | Ki | 5.7400 | 1 | 1 |
| Solute carrier family 22 member 20 | Mus musculus (house mouse) | Ki | 27,542.3000 | 1 | 1 |
| Solute carrier family 22 member 4 | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
| Solute carrier family 22 member 6 | Homo sapiens (human) | IC50 | 0.2700 | 1 | 1 |
| Solute carrier family 22 member 6 | Mus musculus (house mouse) | Ki | 837.2547 | 3 | 3 |
| Solute carrier family 22 member 6 | Rattus norvegicus (Norway rat) | Ki | 2,000.0000 | 1 | 1 |
| Solute carrier family 28 member 3 | Homo sapiens (human) | Ki | 58.0000 | 1 | 2 |
| Solute carrier family 5 member 4 | Homo sapiens (human) | IC50 | 0.0160 | 1 | 1 |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | IC50 | 3.8783 | 2 | 3 |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | Ki | 0.5300 | 1 | 2 |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | IC50 | 3.0132 | 2 | 3 |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | Ki | 2.4450 | 1 | 2 |
| Solute carrier organic anion transporter family member 2B1 | Homo sapiens (human) | IC50 | 4.5000 | 1 | 1 |
| Sorbitol dehydrogenase | Homo sapiens (human) | IC50 | 126.8750 | 3 | 4 |
| Sortase A | Streptococcus mutans | IC50 | 27.2000 | 1 | 1 |
| Sphingomyelin phosphodiesterase | Bos taurus (cattle) | IC50 | 14.1000 | 1 | 1 |
| Sphingomyelin phosphodiesterase | Homo sapiens (human) | IC50 | 19.4200 | 2 | 2 |
| Spike glycoprotein | Betacoronavirus England 1 | IC50 | 0.6700 | 1 | 1 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | IC50 | 0.6700 | 1 | 1 |
| Squalene monooxygenase | Rattus norvegicus (Norway rat) | IC50 | 16.0760 | 3 | 5 |
| Squalene synthase | Rattus norvegicus (Norway rat) | IC50 | 50.0000 | 1 | 1 |
| steroidogenic factor 1 | Homo sapiens (human) | IC50 | 67.5855 | 1 | 2 |
| Sterol O-acyltransferase 1 | Homo sapiens (human) | IC50 | 1,000.0000 | 2 | 2 |
| Sterol O-acyltransferase 1 | Rattus norvegicus (Norway rat) | IC50 | 1,000.0000 | 1 | 1 |
| Stimulator of interferon genes protein | Homo sapiens (human) | IC50 | 137.0000 | 1 | 1 |
| Stromelysin-1 | Homo sapiens (human) | IC50 | 5.5700 | 1 | 1 |
| Structural capsid protein | Human immunodeficiency virus 1 | IC50 | 0.0467 | 1 | 1 |
| Substance-K receptor | Cavia porcellus (domestic guinea pig) | IC50 | 55.4333 | 1 | 6 |
| Substance-P receptor | Cavia porcellus (domestic guinea pig) | IC50 | 55.4333 | 1 | 6 |
| Succinate-semialdehyde dehydrogenase, mitochondrial | Homo sapiens (human) | IC50 | 15.6000 | 1 | 1 |
| Sucrase-isomaltase, intestinal | Homo sapiens (human) | IC50 | 25.1250 | 4 | 4 |
| Sucrase-isomaltase, intestinal | Rattus norvegicus (Norway rat) | IC50 | 357.4286 | 4 | 7 |
| Sucrase-isomaltase, intestinal | Homo sapiens (human) | Ki | 7.3000 | 1 | 1 |
| Sulfhydryl oxidase 1 | Homo sapiens (human) | IC50 | 5.4000 | 1 | 1 |
| SUMO-1 | Homo sapiens (human) | IC50 | 40.6500 | 2 | 2 |
| Synapsin-1 | Bos taurus (cattle) | IC50 | 0.1500 | 1 | 1 |
| Synaptojanin-1 | Homo sapiens (human) | IC50 | 15.9000 | 2 | 2 |
| Synaptojanin-2 | Homo sapiens (human) | IC50 | 3.1700 | 3 | 3 |
| Tat | Human immunodeficiency virus 1 | IC50 | 1.6690 | 1 | 1 |
| TCRAV4S1, partial | Homo sapiens (human) | IC50 | 94.2660 | 1 | 1 |
| Telomerase reverse transcriptase | Homo sapiens (human) | IC50 | 12.8400 | 6 | 6 |
| Testosterone 17-beta-dehydrogenase 3 | Homo sapiens (human) | IC50 | 82.0300 | 2 | 4 |
| Thioredoxin reductase 1, cytoplasmic | Homo sapiens (human) | IC50 | 127.8667 | 3 | 3 |
| Thioredoxin reductase 2, mitochondrial | Homo sapiens (human) | IC50 | 176.8000 | 2 | 2 |
| Thioredoxin reductase 3 | Homo sapiens (human) | IC50 | 176.8000 | 2 | 2 |
| Thiosulfate sulfurtransferase | Homo sapiens (human) | IC50 | 41.0250 | 1 | 4 |
| Thromboxane-A synthase | Homo sapiens (human) | IC50 | 2.9660 | 1 | 1 |
| Thyroid peroxidase | Homo sapiens (human) | IC50 | 3.3800 | 1 | 1 |
| Tissue factor | Homo sapiens (human) | IC50 | 80.0000 | 1 | 1 |
| Tissue factor | Homo sapiens (human) | Ki | 8,000.0000 | 1 | 1 |
| Tissue-type plasminogen activator | Homo sapiens (human) | IC50 | 3.3455 | 1 | 2 |
| Toll-like receptor 2 | Mus musculus (house mouse) | IC50 | 69.2500 | 1 | 1 |
| Toxin B | Clostridioides difficile | IC50 | 0.0172 | 1 | 1 |
| TPA: protein transporter TIM10 | Saccharomyces cerevisiae S288C | IC50 | 5.2900 | 2 | 2 |
| TPA: protein transporter TIM23 | Saccharomyces cerevisiae S288C | IC50 | 0.8800 | 1 | 1 |
| Transcription factor 7-like 2 | Homo sapiens (human) | Ki | 387.2000 | 1 | 1 |
| Transcription factor AP-1 | Homo sapiens (human) | IC50 | 0.0079 | 1 | 1 |
| Transcription factor MafK | Homo sapiens (human) | IC50 | 15.8489 | 1 | 1 |
| Transcription factor p65 | Homo sapiens (human) | IC50 | 16.6000 | 4 | 4 |
| Transcription intermediary factor 1-alpha | Homo sapiens (human) | IC50 | 0.1620 | 1 | 1 |
| Transcription regulator protein BACH1 | Homo sapiens (human) | IC50 | 15.8489 | 1 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | Homo sapiens (human) | IC50 | 14.5833 | 3 | 3 |
| Transient receptor potential cation channel subfamily A member 1 | Rattus norvegicus (Norway rat) | IC50 | 7.5483 | 5 | 6 |
| Transient receptor potential cation channel subfamily M member 8 | Homo sapiens (human) | IC50 | 8.0533 | 3 | 3 |
| Transient receptor potential cation channel subfamily M member 8 | Rattus norvegicus (Norway rat) | IC50 | 0.1600 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | IC50 | 4.8200 | 6 | 7 |
| Transient receptor potential cation channel subfamily V member 2 | Homo sapiens (human) | IC50 | 1.5000 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 2 | Rattus norvegicus (Norway rat) | IC50 | 7.1667 | 3 | 3 |
| Transient receptor potential cation channel subfamily V member 3 | Homo sapiens (human) | IC50 | 66.0000 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 4 | Homo sapiens (human) | IC50 | 1.3000 | 1 | 1 |
| Translin-associated protein X | Homo sapiens (human) | IC50 | 3.5000 | 1 | 1 |
| Translocator protein | Rattus norvegicus (Norway rat) | Ki | 38.4500 | 1 | 1 |
| Transmembrane protease serine 2 | Homo sapiens (human) | IC50 | 0.6700 | 1 | 1 |
| Triosephosphate isomerase | Oryctolagus cuniculus (rabbit) | Ki | 2.6000 | 1 | 1 |
| Trypsin | Sus scrofa (pig) | IC50 | 200.0000 | 1 | 1 |
| Trypsin-1 | Homo sapiens (human) | IC50 | 339.7000 | 2 | 3 |
| Trypsin-2 | Homo sapiens (human) | IC50 | 339.7000 | 2 | 3 |
| Trypsin-3 | Homo sapiens (human) | IC50 | 339.7000 | 2 | 3 |
| Tryptophan 2,3-dioxygenase | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Tubulin alpha-1A chain | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
| Tubulin alpha-1B chain | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
| Tubulin alpha-1C chain | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
| Tubulin alpha-3C chain | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
| Tubulin alpha-3E chain | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
| Tubulin alpha-4A chain | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
| Tubulin beta chain | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
| Tubulin beta-1 chain | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
| Tubulin beta-2A chain | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
| Tubulin beta-2B chain | Bos taurus (cattle) | IC50 | 40.0000 | 1 | 1 |
| Tubulin beta-2B chain | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
| Tubulin beta-3 chain | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
| Tubulin beta-4A chain | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
| Tubulin beta-4B chain | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
| Tubulin beta-6 chain | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
| Tubulin beta-8 chain | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
| Tyrosinase | Homo sapiens (human) | IC50 | 1,604.3850 | 8 | 8 |
| Tyrosinase | Mus musculus (house mouse) | IC50 | 149.3875 | 3 | 4 |
| Tyrosinase | Mus musculus (house mouse) | Ki | 2,308.0000 | 4 | 5 |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | IC50 | 19.0000 | 1 | 2 |
| Tyrosine-protein kinase Fgr | Rattus norvegicus (Norway rat) | IC50 | 3.5000 | 1 | 1 |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | IC50 | 4.2140 | 1 | 1 |
| Tyrosine-protein kinase JAK1 | Homo sapiens (human) | IC50 | 3.3800 | 1 | 1 |
| Tyrosine-protein kinase JAK2 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Tyrosine-protein kinase JAK3 | Homo sapiens (human) | IC50 | 79,432,800,000.0000 | 1 | 1 |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | IC50 | 35.2218 | 4 | 4 |
| Tyrosine-protein kinase Lyn | Rattus norvegicus (Norway rat) | IC50 | 7.5000 | 1 | 1 |
| Tyrosine-protein kinase receptor UFO | Homo sapiens (human) | IC50 | 0.9600 | 1 | 1 |
| Tyrosine-protein kinase SYK | Homo sapiens (human) | IC50 | 17.3500 | 1 | 4 |
| Tyrosine-protein kinase transforming protein Fps | Fujinami sarcoma virus | Ki | 1.8000 | 1 | 1 |
| Tyrosine-protein kinase Yes | Homo sapiens (human) | IC50 | 3.3000 | 1 | 1 |
| Tyrosine-protein kinase Yes | Homo sapiens (human) | Ki | 4.1860 | 1 | 2 |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | IC50 | 112.1750 | 17 | 18 |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | Ki | 5.0000 | 2 | 2 |
| Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens (human) | IC50 | 110.1400 | 5 | 5 |
| Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) | IC50 | 116.2540 | 5 | 5 |
| Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) | IC50 | 23.6333 | 3 | 3 |
| Tyrosine-protein phosphatase non-receptor type 7 | Homo sapiens (human) | IC50 | 75.7000 | 1 | 1 |
| Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens (human) | IC50 | 333.0000 | 1 | 1 |
| Ubiquitin carboxyl-terminal hydrolase 15 | Homo sapiens (human) | IC50 | 31.4000 | 1 | 5 |
| Ubiquitin carboxyl-terminal hydrolase 2 | Homo sapiens (human) | IC50 | 31.4000 | 1 | 5 |
| Ubiquitin carboxyl-terminal hydrolase isozyme L1 | Homo sapiens (human) | IC50 | 31.4000 | 1 | 5 |
| Ubiquitin carboxyl-terminal hydrolase isozyme L3 | Homo sapiens (human) | IC50 | 31.4000 | 1 | 5 |
| Ubiquitin carboxyl-terminal hydrolase isozyme L5 | Homo sapiens (human) | IC50 | 31.4000 | 1 | 5 |
| UDP-glucose 4-epimerase | Homo sapiens (human) | IC50 | 0.0140 | 1 | 1 |
| UDP-glucuronosyltransferase 1-6 | Homo sapiens (human) | Ki | 20.0000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | IC50 | 5.7000 | 2 | 2 |
| unnamed protein product | Aspergillus oryzae RIB40 | IC50 | 52.7195 | 2 | 2 |
| Urease | Canavalia ensiformis (jack bean) | IC50 | 20.0760 | 24 | 24 |
| Urease | Canavalia ensiformis (jack bean) | Ki | 19.8733 | 3 | 3 |
| Urease subunit alpha | Helicobacter pylori 26695 | IC50 | 77.1290 | 8 | 10 |
| Urease subunit alpha | Sporosarcina pasteurii | IC50 | 21.1250 | 2 | 2 |
| Urease subunit alpha | Helicobacter pylori 26695 | Ki | 4.7830 | 2 | 2 |
| Urease subunit beta | Helicobacter pylori 26695 | IC50 | 77.1290 | 8 | 10 |
| Urease subunit beta | Helicobacter pylori 26695 | Ki | 4.7830 | 2 | 2 |
| Urease subunit beta | Helicobacter pylori | IC50 | 21.1100 | 1 | 1 |
| Urokinase-type plasminogen activator | Homo sapiens (human) | IC50 | 19.1130 | 3 | 7 |
| Urokinase-type plasminogen activator | Mus musculus (house mouse) | IC50 | 3.3455 | 1 | 2 |
| Vascular cell adhesion protein 1 | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | IC50 | 0.9100 | 3 | 3 |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | IC50 | 1.5400 | 1 | 1 |
| Vasopressin V2 receptor | Homo sapiens (human) | IC50 | 20.3282 | 3 | 6 |
| Vif | Human immunodeficiency virus 1 | IC50 | 11.6467 | 1 | 3 |
| Voltage-dependent T-type calcium channel subunit alpha-1G | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Voltage-dependent T-type calcium channel subunit alpha-1H | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Xanthine dehydrogenase/oxidase | Bos taurus (cattle) | IC50 | 25.9200 | 5 | 8 |
| Xanthine dehydrogenase/oxidase | Homo sapiens (human) | IC50 | 85.1714 | 6 | 22 |
| Xanthine dehydrogenase/oxidase | Bos taurus (cattle) | Ki | 1.2000 | 1 | 1 |
| Xanthine dehydrogenase/oxidase | Homo sapiens (human) | Ki | 0.2800 | 1 | 1 |